Miami, FL, Oct. 22, 2026 (GLOBE NEWSWIRE) — Tecnoglass Holdings Inc. (NYSE: TGLS) (“Tecnoglass” or the “Company”), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced it will release financial results for the third quarter 2026 before the market opens on Thursday, November 5, 2026. Management will host a webcast and conference call that same day at 10:00 a.m. Eastern time to review the Company’s results.

Webcast and Conference Call

The conference call will be broadcast live over the Internet. Additionally, a slide presentation will accompany the conference call. To listen to the call and view the slides, please visit the Investors section of Tecnoglass’ website at www.tecnoglass.com. Please go to the website at least 15 minutes early to register, download and install any necessary audio software. For those unable to access the webcast, the conference call will be accessible by dialing 1-844-676-5131 (domestic) or 1-412-634-6589 (international). Upon dialing in, please request to join the Tecnoglass Third Quarter 2026 Earnings Conference Call.

To listen to a telephonic replay of the conference call, dial toll-free 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and enter pass code 10212425.

About Tecnoglass

Tecnoglass Holdings Inc. is a leading producer of high-end aluminum and vinyl windows and architectural glass serving the multi-family, single-family, and commercial end markets. Tecnoglass is the second largest glass fabricator serving the U.S. and the #1 architectural glass transformation company in Latin America. Located in Barranquilla, Colombia, the Company’s 5.8 million square foot, vertically integrated, and state-of-the-art manufacturing complex provide efficient access to nearly 1,000 customers in North, Central and South America, with the United States accounting for over 95% of total revenues. Tecnoglass’ tailored, high-end products are found on some of the world’s most distinctive properties, including One Thousand Museum (Miami), Paramount (Miami), Salesforce Tower (San Francisco), Via 57 West (NY), Hub50House (Boston), Aeropuerto Internacional El Dorado (Bogotá), One Plaza (Medellín), Pabellon de Cristal (Barranquilla). For more information, please visit www.tecnoglass.com or view our corporate video at https://www.youtube.com/watch?v=qD3AKBv4EkU.

Investor Relations:

Santiago Giraldo
CFO
305-503-9062
investorrelations@tecnoglass.com

NEW YORK, Oct. 22, 2026 (GLOBE NEWSWIRE) — Valley National Bancorp (NASDAQ: VLY), the holding company for Valley National Bank, today reported net income for the third quarter 2026 of $206.3 million, or $0.36 per diluted common share, as compared to the second quarter 2026 net income of $170.9 million, or $0.29 per diluted common share, and net income of $163.4 million, or $0.28 per diluted common share, for the third quarter 2025. Excluding all non-core income and charges, our adjusted net income (a non-GAAP measure) was $206.4 million, or $0.36 per diluted common share, for the third quarter 2026, $172.8 million, or $0.30 per diluted common share, for the second quarter 2026, and $164.1 million, or $0.28 per diluted common share, for the third quarter 2025. See further details below, including a reconciliation of our non-GAAP adjusted net income, in the “Consolidated Financial Highlights” tables.

Ira Robbins, CEO, commented, “Our third quarter results demonstrate the continued improvement in Valley’s profitability. Strong revenue growth and disciplined expense management drove record quarterly net income for Valley and an efficiency ratio below 50 percent. We remain on track to achieve, and likely exceed, our previously stated return on average tangible common equity goal of 15 percent by the end of 2027. We believe that we are structurally well-positioned to navigate a range of potential interest rate scenarios while driving relative net interest margin outperformance. Combined with our strong capital and liquidity, this positioning gives us the flexibility to keep growing alongside our clients as we execute on our strategic priorities.”

Mr. Robbins continued, “Our pending acquisitions of Providence Financial Corporation and Bluevine Inc. are a natural extension of our strategy to further optimize our funding base. Providence will enhance our presence in the Chicagoland market, while Bluevine is expected to expand our ability to serve small businesses nationwide through differentiated digital capabilities. Together, these transactions will strengthen our core deposit franchise, broaden our growth opportunities and support sustainable long-term value creation for shareholders.”

Key financial highlights for the third quarter 2026:

  • Net Interest Margin and Income: Our net interest margin on a tax equivalent basis of 3.28 percent for the third quarter 2026 increased 8 basis points and 23 basis points from the second quarter 2026 and third quarter 2025, respectively. Net interest income on a tax equivalent basis of $506.8 million for the third quarter 2026 increased $18.4 million and $59.3 million compared to the second quarter 2026 and third quarter 2025, respectively. The increases from the second quarter 2026 were mainly due to upward repricing of adjustable interest rate loans, higher yields on new loan originations, an increase in average loans and one additional day during the third quarter 2026, partially offset by higher average time deposits and an increase in the cost of certain non-maturity deposits. See additional details in the “Net Interest Income and Margin” and “Other Borrowings” sections below.
  • Deposits: Total deposit balances increased $1.1 billion to $55.2 billion at September 30, 2026 as compared to $54.1 billion at June 30, 2026 primarily attributable to an increase in direct customer deposits during the third quarter 2026. The growth in direct customer deposits was mainly driven by inflows of non-maturity interest bearing deposits from commercial banking customers, as well as retail CD offerings during the third quarter 2026. See the “Deposits” section below for more details.
  • Loan Portfolio: Total loans increased $722.7 million, or 5.5 percent on an annualized basis, to $53.2 billion at September 30, 2026 from June 30, 2026 mostly due to increases of $363.0 million and $343.5 million in commercial and industrial (C&I) loans and total commercial real estate (CRE) loans, respectively. Loan originations from a range of relationship-driven small to midsize clients continued to drive C&I loan growth during the third quarter 2026, while new owner occupied loans and an uptick in construction loan activity were the primary drivers of the increase in CRE loans at September 30, 2026. Our CRE loan concentration ratio (defined as total CRE loans held for investment and held for sale, excluding owner occupied loans, as a percentage of total risk-based capital) declined to approximately 312 percent at September 30, 2026 from 317 percent at June 30, 2026. See the “Loans” section below for more details.
  • Allowance and Provision for Credit Losses for Loans: The allowance for credit losses for loans totaled $600.5 million and $606.9 million at September 30, 2026 and June 30, 2026, respectively, representing 1.13 percent and 1.16 percent of total loans at each respective date. During the third quarter 2026, we recorded a provision for credit losses for loans of $30.7 million as compared to $29.2 million and $19.2 million for the second quarter 2026 and third quarter 2025, respectively. See the “Credit Quality” section below for more details.
  • Credit Quality: Total internally criticized and classified loans as a percentage of total loans declined to 7.1 percent at September 30, 2026 from 7.3 percent at June 30, 2026. Net loan charge-offs totaled $37.1 million for the third quarter 2026 as compared to $22.0 million and $14.6 million for the second quarter 2026 and third quarter 2025, respectively. Total accruing past due loans (i.e., loans past due 30 days or more and still accruing interest) decreased $25.7 million to $154.5 million, or 0.29 percent of total loans, at September 30, 2026 as compared to $180.2 million, or 0.34 percent of total loans, at June 30, 2026. The decrease was mainly due to migration of a few larger CRE loans to non-accrual category and, to a lesser extent, a decrease in early stage residential mortgage loan delinquencies. Non-accrual loans totaled $511.4 million, or 0.96 percent of total loans, at September 30, 2026 as compared to $462.6 million, or 0.88 percent of total loans, at June 30, 2026. See the “Credit Quality” section below for more details.
  • Non-Interest Income: Non-interest income increased $5.0 million to $78.7 million for the third quarter 2026 as compared to the second quarter 2026 largely due to a $6.4 million increase in other income primarily driven by recovery income from legal settlements and net valuation gains on certain fintech investments at September 30, 2026. Wealth management and trust fees also increased $4.5 million mainly due to a higher volume of transaction-related tax credit advisory fees. These increases were partially offset by lower bank owned life insurance and capital markets income.
  • Non-Interest Expense: Non-interest expense decreased $1.2 million to $310.0 million for the third quarter 2026 as compared to the second quarter 2026. The overall decrease was largely driven by a $4.4 million decline in professional and legal fees due to lower business transformation-related consulting fees during the third quarter 2026, partially offset by higher amortization of tax credit investments. During the third quarter 2026, we recorded $3.1 million of merger related expenses (primarily reported within professional and legal fees and other expense) related to our pending acquisitions of Providence Financial Corporation (Providence) and Bluevine Inc. (Bluevine). See additional information below.
  • Income Tax Expense: Income tax expense totaled $37.3 million and $49.6 million for the third and second quarters of 2026, respectively. Our effective tax rate was 15.3 percent for the third quarter 2026 as compared to 22.5 percent for the second quarter 2026. The decrease in income tax expense and the effective tax rate as compared to the linked second quarter 2026 was due to the availability and purchase of additional tax credits in excess of amounts previously anticipated during the third quarter 2026.
  • Efficiency Ratio: Our efficiency ratio was 49.38 percent for the third quarter 2026 as compared to 52.11 percent and 53.37 percent for the second quarter 2026 and third quarter 2025, respectively. See the “Consolidated Financial Highlights” tables below for additional information regarding our non-GAAP measures.
  • Performance Ratios: Annualized return on average assets (ROAA), shareholders’ equity (ROAE) and tangible common shareholders’ equity (ROATCE) were 1.24 percent, 10.36 percent and 14.24 percent for the third quarter 2026, respectively. Annualized ROAA, ROAE, and ROATCE, adjusted for non-core income and charges, were 1.24 percent, 10.36 percent and 14.24 percent for the third quarter 2026, respectively. See the “Consolidated Financial Highlights” tables below for additional information regarding our non-GAAP measures.

On August 25, 2026, Valley announced that it will acquire Providence, and its principal subsidiary, Providence Bank & Trust headquartered in South Holland, Illinois. We believe the acquisition of this high-performing commercial bank, with $1.6 billion in total assets and a 14-branch network as of June 30, 2026, will provide an established physical delivery channel in the Chicagoland area to supplement Valley’s existing commercial presence in the market. The acquisition is expected to close in early 2027, subject to standard regulatory approvals, approval of Providence’s shareholders, and the satisfaction or waiver of other customary closing conditions.

On September 28, 2026, Valley also announced that it will acquire Bluevine, a leading nationwide digital banking platform for small businesses headquartered in Jersey City, New Jersey. Upon closing, Bluevine will bring Valley a scaled, high-growth digital small business platform; low-cost, digitally-sourced deposit relationships; and an established suite of integrated banking, payments, lending and financial-management solutions designed for small businesses across the country. The acquisition is expected to close in early 2027, subject to standard regulatory approvals, and the satisfaction or waiver of other customary closing conditions.

Net Interest Income and Margin

Net interest income on a tax equivalent basis of $506.8 million for the third quarter 2026 increased $18.4 million and $59.3 million compared to the second quarter 2026 and the third quarter 2025, respectively. Interest income on a tax equivalent basis increased $27.8 million to $858.5 million for the third quarter 2026 as compared to the second quarter 2026. The increase was primarily due to higher yields on adjustable interest rate loans, the origination of higher-yielding loans within the C&I and CRE loan portfolios, an overall increase in average loan balances and one additional day during the third quarter 2026 as compared to the second quarter 2026. Total interest expense increased $9.4 million to $351.7 million for the third quarter 2026 as compared to the second quarter 2026 mainly due to an increase in average time deposits during the third quarter 2026, as well as the higher cost of certain non-maturity deposits. See the “Deposits” and “Other Borrowings” sections below for more details.

Net interest margin on a tax equivalent basis of 3.28 percent for the third quarter 2026 increased 8 basis points from 3.20 percent for the second quarter 2026 and 23 basis points from 3.05 percent for the third quarter 2025. The yield on average interest earning assets increased by 11 basis points to 5.55 percent on a linked quarter basis largely due to the higher yields on new loan originations during the third quarter 2026 and upward repricing of adjustable interest rate loans. The overall cost of average interest bearing liabilities increased by 6 basis points to 3.16 percent for the third quarter 2026 as compared to the second quarter 2026 mostly due to the higher cost of both non-maturity and time deposits. Our cost of total average deposits was 2.33 percent for the third quarter 2026 as compared to 2.28 percent and 2.69 percent for the second quarter 2026 and third quarter 2025, respectively.

Loans, Deposits and Other Borrowings

Loans. Total loans increased $722.7 million, or 5.5 percent on an annualized basis, to $53.2 billion at September 30, 2026 from June 30, 2026. C&I loans increased $363.0 million, or 12.1 percent on an annualized basis, to $12.3 billion at September 30, 2026 from June 30, 2026, primarily driven by new originations from relationship-driven small to midsize clients across several markets, with particularly strong loan production in New York, Florida, California, and Arizona. Total CRE (including construction) loans increased $343.5 million to $30.7 billion at September 30, 2026 from June 30, 2026 due, in large part, to continued momentum in new owner occupied CRE loan originations from our healthcare vertical and the Florida market, as well as an uptick in construction loan advances primarily in New York and Florida. Non-owner occupied loans decreased $145.7 million from June 30, 2026 mainly due to our continued targeted runoff of transactional/non-relationship loans, which outpaced limited new originations in this category during the third quarter 2026. Residential mortgage loans increased $101.5 million from June 30, 2026 mainly due to continued retention of most new loan origination activity and the modest levels of prepayments. Total consumer loans decreased $85.3 million from June 30, 2026 primarily due to a $118.1 million decrease in automobile loans as normal loan repayments outpaced consumer demand which was constrained by several factors, including gasoline prices and the high level of market interest rates.

Deposits. Actual ending balances for deposits increased $1.1 billion to $55.2 billion at September 30, 2026 from June 30, 2026 mainly due to a $730.9 million increase in the savings, NOW and money market deposits category and a $482.1 million increase in time deposits, partially offset by a $102.8 million decline in non-interest bearing deposits. The increase in savings, NOW and money market deposits from June 30, 2026 was mostly attributable to inflows from our commercial banking customers, partially offset by lower indirect customer money market deposit balances. The increase in time deposits was largely driven by higher indirect customer CD balances and deposits generated from our targeted retail CD offerings. Total indirect customer deposits (consisting of both brokered time and money market deposits) totaled $5.3 billion at both September 30, 2026 and June 30, 2026. Non-interest bearing deposits; savings, NOW and money market deposits; and time deposits represented approximately 23 percent, 53 percent and 24 percent of total deposits at both September 30, 2026 and June 30, 2026.

Other Borrowings. Short-term borrowings decreased $383.2 million to $50.3 million at September 30, 2026 from June 30, 2026 mainly due to maturity and repayment of $375 million of short-term FHLB advances during the third quarter 2026. Long-term borrowings totaled $2.6 billion at September 30, 2026 and remained relatively unchanged as compared to June 30, 2026.

Credit Quality

Non-Performing Assets (NPAs). NPAs, consisting of non-accrual loans, other real estate owned (OREO) and other repossessed assets, increased $46.0 million to $513.8 million at September 30, 2026 from June 30, 2026. Non-accrual loans increased $48.8 million to $511.4 million, or 0.96 percent of total loans, at September 30, 2026 as compared to $462.6 million, or 0.88 percent of total loans, at June 30, 2026. The increase was primarily attributable to a $30.1 million construction loan that was placed on non-accrual status during the third quarter 2026, as well as higher levels of non-accrual C&I loans. The $30.1 million construction loan is considered well-secured and did not require a specific reserve within our allowance for credit losses for loans at September 30, 2026 based upon the estimated value of the underlying collateral. Non-accrual CRE loans decreased $3.0 million to $253.1 million at September 30, 2026 from June 30, 2026, primarily reflecting repayments and partial charge-offs, partially offset by the migration of three CRE loans previously reported as loans 30 to 59 days past due at June 30, 2026 to non-accrual status during the third quarter 2026.

Accruing Past Due Loans. Total accruing past due loans (i.e., loans past due 30 days or more and still accruing interest) decreased $25.7 million to $154.5 million, or 0.29 percent of total loans, at September 30, 2026 as compared to $180.2 million, or 0.34 percent of total loans, at June 30, 2026.

Loans 30 to 59 days past due decreased $41.7 million to $109.3 million at September 30, 2026 as compared to June 30, 2026 primarily due to the migration of three CRE loans totaling $24.7 million, net of partial charge-offs of $9.1 million during the third quarter 2026, to non-accrual loans at September 30, 2026, as well as lower residential mortgage loan delinquencies. Loans 60 to 89 days past due increased $14.8 million to $27.9 million at September 30, 2026 as compared to June 30, 2026 mainly due to one CRE loan relationship totaling $10.9 million and higher residential mortgage loans delinquencies. Loans 90 days or more past due and still accruing interest increased $1.3 million to $17.3 million at September 30, 2026 as compared to June 30, 2026 largely due to the third quarter 2026 migration of a $4.0 million CRE loan previously reported in the 30 to 59 days past due delinquency category at June 30, 2026, partially offset by lower residential mortgage and C&I loans delinquencies. All loans 90 days or more past due and still accruing interest are well-secured and in the process of collection.

Allowance for Credit Losses for Loans and Unfunded Commitments. The following table summarizes the allocation of the allowance for credit losses to loan categories and the allocation as a percentage of each loan category at September 30, 2026, June 30, 2026, and September 30, 2025:

    September 30, 2026   June 30, 2026   September 30, 2025
          Allocation         Allocation         Allocation
          as a % of         as a % of         as a % of
    Allowance
  Loan   Allowance
  Loan   Allowance
  Loan
    Allocation
  Category   Allocation
  Category   Allocation
  Category
    ($ in thousands)
Loan Category:                              
Commercial and industrial loans   $ 211,513     1.72 %   $ 198,910     1.66 %   $ 161,848     1.50 %
Commercial real estate loans:                              
Commercial real estate     252,903     0.90       268,445     0.96       297,685     1.14  
Construction     46,490     1.75       50,623     2.05       51,908     2.06  
Total commercial real estate loans     299,393     0.98       319,068     1.05       349,593     1.22  
Residential mortgage loans     47,376     0.78       48,905     0.82       51,094     0.88  
Consumer loans:                              
Home equity     4,341     0.58       4,333     0.59       3,735     0.57  
Auto and other consumer     18,177     0.54       19,384     0.56       18,730     0.55  
Total consumer loans     22,518     0.55       23,717     0.57       22,465     0.56  
Allowance for loan losses     580,800     1.09       590,600     1.13       585,000     1.19  
Allowance for unfunded credit commitments     19,700           16,320           13,604      
Total allowance for credit losses for loans   $ 600,500         $ 606,920         $ 598,604      
Allowance for credit losses for loans as a % of total loans         1.13 %         1.16 %         1.21 %

Our loan portfolio, totaling $53.2 billion at September 30, 2026, had net loan charge-offs totaling $37.1 million for the third quarter 2026 as compared to $22.0 million and $14.6 million for the second quarter 2026 and the third quarter 2025, respectively. Gross loan charge-offs totaled $40.1 million for the third quarter 2026 and included (i) an $11.6 million partial charge-off of a C&I loan with $2.0 million of allocated reserves within our allowance for credit losses for loans at September 30, 2026 and (ii) partial charge-offs totaling $9.1 million related to the aforementioned three non-accrual CRE loans totaling $24.7 million, net of the charge-offs, with no related allocated reserves within our allowance for credit losses for loans at September 30, 2026.

The allowance for credit losses for loans, comprised of our allowance for loan losses and unfunded credit commitments, as a percentage of total loans was 1.13 percent at September 30, 2026, 1.16 percent at June 30, 2026, and 1.21 percent at September 30, 2025. For the third quarter 2026, the provision for credit losses for loans totaled $30.7 million as compared to $29.2 million and $19.2 million for the second quarter 2026 and third quarter 2025, respectively. The third quarter 2026 provision was mainly impacted by increases in (i) the economic forecast component of our reserve, (ii) non-economic qualitative reserves and (iii) specific reserves associated with certain collateral dependent loans, partially offset by (iv) a decline in quantitative reserves largely within certain CRE loan categories, including construction loans, at September 30, 2026.

Capital Adequacy

Valley’s total risk-based capital, Tier 1 capital, common equity tier 1 capital, and Tier 1 leverage capital ratios were 13.70 percent, 11.36 percent, 10.71 percent and 9.54 percent, respectively, at September 30, 2026 as compared to 13.77 percent, 11.37 percent, 10.71 percent and 9.49 percent, respectively, at June 30, 2026. During the third quarter 2026, we repurchased 2.5 million shares of our common stock at an average price of $13.86 under our current stock repurchase plan.

Investor Conference Call

Valley’s CEO, Ira Robbins, will host a conference call on Thursday, October 22, 2026 at 8:30 AM (ET) to discuss Valley’s third quarter 2026 earnings and related matters. Interested parties should pre-register using this link: https://register-conf.media-server.com/register to receive the dial-in number and a personal PIN, which are required to access the conference call. The teleconference will also be webcast live: https://edge.media-server.com/ and archived on Valley’s website through Monday, November 23, 2026. Investor presentation materials will be made available prior to the conference call at www.valley.com.

About Valley

As the principal subsidiary of Valley National Bancorp (NASDAQ: VLY), Valley National Bank is a regional financial institution with over $67 billion in assets. Founded in 1927, Valley has more than 220 branch locations and commercial offices nationwide and serves clients across New Jersey, New York, Florida, Alabama, California, Illinois, Pennsylvania and Arizona. Valley delivers a full range of consumer, commercial, and wealth management solutions designed to support everything from homeownership and business growth to long-term financial planning. Big enough to support complex financial needs and small enough to stay deeply connected, Valley is grounded in a relationship-led approach focused on understanding people first. That same relationship-led approach guides Valley’s commitment to community investment and responsible corporate citizenship. To learn more, visit www.valley.com or call the Valley Customer Care Center at 800-522-4100.

Forward-Looking Statements

The foregoing contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are not historical facts and include expressions about management’s confidence and strategies and management’s expectations about our business, new and existing programs and products, the Transactions (as defined below) and other mergers or acquisitions, relationships, opportunities, taxation, technology, market conditions and economic expectations. These statements may be identified by forward-looking terminology such as “intend,” “should,” “expect,” “believe,” “position,” “view,” “opportunity,” “allow,” “continues,” “reflects,” “would,” “could,” “typically,” “usually,” “anticipate,” “may,” “estimate,” “outlook,” “project” or similar statements or variations of such terms. Such forward-looking statements involve certain risks and uncertainties. Actual results may differ materially from such forward-looking statements. Factors that may cause actual results to differ materially from those contemplated in these forward-looking statements include, but are not limited to:

  • risks and uncertainties relating to Valley’s pending acquisitions of Providence and Bluevine (together, the “Transactions”), including, but not limited to: the possibility that the Transactions may not be completed when expected or at all, including as a result of delays in obtaining, or the failure to obtain, required regulatory or other approvals or the failure to satisfy other closing conditions, including approval by Providence shareholders; the occurrence of any event that could give rise to the right of any party to terminate the merger or other agreement; the possibility that the anticipated benefits of the Transactions, including potential cost savings, synergies, and earnings accretion, will not be realized when expected or at all; the possibility that the Transactions may be more expensive to complete than anticipated, including as a result of unexpected factors or events; diversion of management and attention from ongoing business operations; costs or difficulties relating to integration matters might be greater than expected; the inability to retain customers and qualified employees of Providence and Bluevine; potential business disruption or adverse reactions or changes to business, customer or employee relationships as a result of the Transactions; and changes in estimates of non-recurring charges related to the Transactions;
  • the impact of market interest rates and monetary and fiscal policies of the U.S. federal government and its agencies in connection with prolonged inflationary pressures, which could have a material adverse effect on our clients, our business, our employees, and our ability to provide services to our customers;
  • the impact of unfavorable macroeconomic conditions or downturns, including instability or volatility in financial markets resulting from the impact of tariffs/import fees and other trade policies and practices, any retaliatory actions, changes in energy commodity prices, related market uncertainty, or other factors; U.S. government debt default or rating downgrade; unanticipated loan delinquencies; loss of collateral; decreased service revenues; increased business disruptions or failures; reductions in employment; and other potential negative effects on our business, employees or clients caused by factors outside of our control, such as new legislation and policy changes under the current U.S. presidential administration, any shutdown of the U.S. federal government, geopolitical instabilities or events, including ongoing conflicts in the Middle East, natural and other disasters, including severe weather events and other climate-related risks, health emergencies, acts of terrorism, or other external events;
  • the impact of any potential instability within the U.S. financial sector or future bank failures, including the possibility of a run on deposits by a coordinated deposit base, and the impact of any actual or perceived concerns regarding the soundness, or creditworthiness, of other financial institutions, including any resulting disruption within the financial markets, increased expenses, including FDIC insurance assessments, or adverse impact on our stock price, deposits or our ability to borrow or raise capital;
  • the impact of negative public opinion regarding Valley or banks in general that damages our reputation and adversely impacts business and revenues;
  • changes in the statutes, regulations, policies, enforcement priorities, or composition of the federal bank regulatory agencies;
  • the loss of or decrease in lower-cost funding sources within our deposit base;
  • investigations, damage verdicts, settlements or restrictions related to existing or potential class action litigation or individual litigation arising from claims of violations of laws or regulations, contractual claims, breach of fiduciary responsibility, negligence, fraud, environmental laws, patent, trademark or other intellectual property infringement, misappropriation or other violation, employment-related claims, and other matters;
  • a prolonged downturn and contraction in the economy, as well as any decline in commercial real estate values collateralizing a significant portion of our loan portfolio;
  • higher or lower than expected income tax expense or tax rates, including increases or decreases resulting from changes in uncertain tax position liabilities, tax laws, regulations, and case law;
  • the inability to grow customer deposits to keep pace with the level of loan growth;
  • a material change in our allowance for credit losses due to forecasted economic conditions and/or unexpected credit deterioration in our loan and investment portfolios;
  • the need to supplement debt or equity capital to maintain or exceed internal capital thresholds;
  • changes in our business, strategy, market conditions or other factors that may negatively impact the estimated fair value of our goodwill and other intangible assets and result in future impairment charges;
  • greater than expected technology-related costs due to, among other factors, prolonged or failed implementations, additional project staffing and obsolescence caused by continuous and rapid market innovations;
  • increased competitive challenges and competitive pressure on pricing of our products and services;
  • our ability to stay current with rapid technological changes and evolving legal and regulatory requirements in the financial services industry, including developments relating to the use of artificial intelligence, blockchain, and related regulatory developments, as well as our ability to effectively assess and monitor the effects of, and risks associated with, the implementation and use of such technology;
  • cyberattacks, ransomware attacks, computer viruses, malware or other cybersecurity incidents that may breach the security of our or our third-party service providers’ websites or other systems or networks to obtain unauthorized access to personal, confidential, proprietary or sensitive information, destroy data, disable or degrade service, or sabotage our systems or networks, and the increasing sophistication of such attacks and use of targeted tactics against the financial services industry;
  • any disruption of our systems and network, or those of our third-party service providers, resulting from events that are wholly or partially beyond our control, including, for example, electrical, telecommunications, or other major service outages, or actions by employees, which may give rise to financial loss or liability;
  • results of examinations by the Office of the Comptroller of the Currency (OCC), the Federal Reserve Bank, the Consumer Financial Protection Bureau and other regulatory authorities, including the possibility that any such regulatory authority may, among other things, require us to increase our allowance for credit losses, write-down assets, reimburse customers, change the way we do business, or limit or eliminate certain other banking activities;
  • application of heightened regulatory standards for certain large insured national banks, and the expenses we will incur to develop policies, programs, and systems that comply with the enhanced standards applicable to us;
  • our inability or determination not to pay dividends at current levels, or at all, because of inadequate earnings, regulatory restrictions or limitations, changes in our capital requirements, or a decision to increase capital by retaining more earnings;
  • unanticipated loan delinquencies, loss of collateral, decreased service revenues, and other potential negative effects on our business caused by severe weather and other climate-related risks, pandemics or other public health crises, acts of terrorism or other external events;
  • our ability to successfully execute our business plan and strategic initiatives; and
  • unexpected significant declines in the loan portfolio due to the lack of economic expansion, increased competition, large prepayments, risk mitigation strategies, changes in regulatory lending guidance or other factors.

A detailed discussion of factors that could affect our results is included in our SEC filings, including Item 1A. “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2025.

We undertake no duty to update any forward-looking statement to conform the statement to actual results or changes in our expectations, except as required by law. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.

–Tables to Follow–

VALLEY NATIONAL BANCORP
CONSOLIDATED FINANCIAL HIGHLIGHTS

SELECTED FINANCIAL DATA
    Three Months Ended   Nine Months Ended
    September 30,   June 30,   September 30,   September 30,
($ in thousands, except for share data and stock price)     2026       2026       2025       2026       2025  
FINANCIAL DATA:                    
Net interest income – FTE (1)   $ 506,794     $ 488,388     $ 447,473     $ 1,467,983     $ 1,302,525  
Net interest income     505,451       487,024       446,224       1,464,000       1,298,737  
Non-interest income     78,700       73,711       64,887       221,247       185,785  
Total revenue     584,151       560,735       511,111       1,685,247       1,484,522  
Non-interest expense     309,958       311,123       281,985       931,007       842,725  
Pre-provision net revenue     274,193       249,612       229,126       754,240       641,797  
Provision for credit losses     30,641       29,164       19,171       81,061       119,631  
Income tax expense     37,252       49,563       46,600       132,081       119,586  
Net income     206,300       170,885       163,355       541,098       402,580  
Dividends on preferred stock     7,335       7,316       7,644       21,868       21,547  
Net income available to common shareholders   $ 198,965     $ 163,569     $ 155,711     $ 519,230     $ 381,033  
Weighted average number of common shares outstanding:                    
Basic     552,358,147       553,740,562       560,504,275       553,946,293       560,154,649  
Diluted     556,266,986       556,958,049       563,636,933       557,405,979       563,905,535  
Per common share data:                    
Basic earnings   $ 0.36     $ 0.30     $ 0.28     $ 0.94     $ 0.68  
Diluted earnings     0.36       0.29       0.28       0.93       0.68  
Cash dividends declared     0.11       0.11       0.11       0.33       0.33  
Closing stock price – high     15.19       14.78       11.10       15.19       11.10  
Closing stock price – low     12.62       12.42       9.18       11.66       7.87  
FINANCIAL RATIOS:                    
Net interest margin     3.27 %     3.19 %     3.04 %     3.21 %     3.00 %
Net interest margin – FTE (1)     3.28       3.20       3.05       3.22       3.01  
Annualized return on average assets     1.24       1.04       1.04       1.10       0.86  
Annualized return on average shareholders’ equity     10.36       8.65       8.58       9.12       7.13  
NON-GAAP FINANCIAL DATA AND RATIOS: (2)                    
Basic earnings per share, as adjusted   $ 0.36     $ 0.30     $ 0.28     $ 0.95     $ 0.68  
Diluted earnings per share, as adjusted     0.36       0.30       0.28       0.94       0.68  
Annualized return on average assets, as adjusted     1.24 %     1.05 %     1.04 %     1.12 %     0.87 %
Annualized return on average shareholders’ equity, as adjusted     10.36       8.75       8.62       9.24       7.16  
Annualized return on average tangible common shareholders’ equity     14.24       11.91       12.05       12.58       10.08  
Annualized return on average tangible common shareholders’ equity, as adjusted     14.24       12.05       12.10       12.74       10.13  
Efficiency ratio     49.38       52.11       53.37       51.49       54.79  
                     
AVERAGE BALANCE SHEET ITEMS:                    
Assets   $ 66,506,401     $ 65,584,823     $ 63,046,215     $ 65,435,632     $ 62,224,382  
Interest earning assets     61,834,602       61,057,362       58,623,153       60,878,033       57,695,831  
Loans     52,683,932       51,884,173       49,270,853       51,620,023       48,988,393  
Interest bearing liabilities     44,550,998       44,160,202       42,677,630       44,025,506       41,947,670  
Deposits     54,163,381       53,174,301       51,167,324       53,243,510       50,080,358  
Shareholders’ equity     7,967,868       7,901,688       7,616,810       7,908,818       7,533,660  

    As of
BALANCE SHEET ITEMS:   September 30,   June 30,   March 31,   December 31,   September 30,
(In thousands)     2026       2026       2026       2025       2025  
Assets   $ 67,470,879     $ 66,318,308     $ 64,466,585     $ 64,132,725     $ 63,018,614  
Total loans     53,189,984       52,467,251       50,828,820       50,136,728       49,272,823  
Deposits     55,228,795       54,118,607       52,859,621       52,183,093       51,175,758  
Shareholders’ equity     7,896,552       7,917,144       7,828,443       7,807,698       7,695,374  
                     
LOANS:                    
(In thousands)                    
Commercial and industrial   $ 12,324,253     $ 11,961,242     $ 11,104,079     $ 10,961,519     $ 10,757,857  
Commercial real estate:                    
Non-owner occupied     11,001,011       11,146,663       11,503,874       11,571,127       11,674,103  
Multifamily     9,024,673       9,034,186       8,588,462       8,571,713       8,394,694  
Owner occupied     8,008,473       7,692,877       7,132,254       6,629,909       6,097,319  
Total     28,034,157       27,873,726       27,224,590       26,772,749       26,166,116  
Construction     2,658,202       2,475,109       2,485,387       2,471,233       2,517,258  
Total commercial real estate     30,692,359       30,348,835       29,709,977       29,243,982       28,683,374  
Residential mortgage     6,084,398       5,982,941       5,869,070       5,826,192       5,795,395  
Consumer:                    
Home equity     748,969       728,623       701,136       687,680       655,872  
Automobile     2,031,983       2,150,089       2,198,102       2,184,600       2,191,976  
Other consumer     1,308,022       1,295,521       1,246,456       1,232,755       1,188,349  
Total consumer loans     4,088,974       4,174,233       4,145,694       4,105,035       4,036,197  
Total loans   $ 53,189,984     $ 52,467,251     $ 50,828,820     $ 50,136,728     $ 49,272,823  
                     
CAPITAL RATIOS:                    
Book value per common share   $ 13.70     $ 13.67     $ 13.48     $ 13.39     $ 13.09  
Tangible book value per common share (2)     10.15       10.13       9.94       9.85       9.57  
Tangible common equity to tangible assets (2)     8.53 %     8.71 %     8.82 %     8.82 %     8.79 %
Tier 1 leverage capital     9.54       9.49       9.56       9.63       9.52  
Common equity tier 1 capital     10.71       10.71       10.91       10.99       11.00  
Tier 1 risk-based capital     11.36       11.37       11.60       11.69       11.72  
Total risk-based capital     13.70       13.77       13.66       13.77       13.83  

    Three Months Ended   Nine Months Ended
ALLOWANCE FOR CREDIT LOSSES:   September 30,   June 30,   September 30,   September 30,
($ in thousands)     2026       2026       2025       2026       2025  
Allowance for credit losses for loans                    
Beginning balance – Allowance for credit losses for loans   $ 606,920     $ 599,800     $ 594,020     $ 596,100     $ 573,328  
Loans charged-off:                    
Commercial and industrial     (17,656 )     (9,838 )     (2,745 )     (30,276 )     (56,390 )
Commercial real estate     (19,075 )     (14,434 )     (11,776 )     (47,265 )     (38,659 )
Construction     —       —       (541 )     —       (1,704 )
Residential mortgage     —       —       (26 )     —       (72 )
Total consumer     (3,327 )     (3,354 )     (1,478 )     (9,944 )     (5,831 )
Total loans charged-off     (40,058 )     (27,626 )     (16,566 )     (87,485 )     (102,656 )
Charged-off loans recovered:                    
Commercial and industrial     1,268       1,669       1,169       4,335       4,768  
Commercial real estate     700       2,790       206       3,837       643  
Construction     —       —       —       —       455  
Residential mortgage     26       41       56       150       261  
Total consumer     986       1,080       548       2,495       2,164  
Total loans recovered     2,980       5,580       1,979       10,817       8,291  
Total net charge-offs     (37,078 )     (22,046 )     (14,587 )     (76,668 )     (94,365 )
Provision for credit losses for loans     30,658       29,166       19,171       81,068       119,641  
Ending balance   $ 600,500     $ 606,920     $ 598,604     $ 600,500     $ 598,604  
Components of allowance for credit losses for loans:                    
Allowance for loan losses   $ 580,800     $ 590,600     $ 585,000     $ 580,800     $ 585,000  
Allowance for unfunded credit commitments     19,700       16,320       13,604       19,700       13,604  
Allowance for credit losses for loans   $ 600,500     $ 606,920     $ 598,604     $ 600,500     $ 598,604  
Components of provision for credit losses for loans:                    
Provision for credit losses for loans   $ 27,278     $ 28,146     $ 20,087     $ 74,068     $ 120,515  
Provision (credit) for unfunded credit commitments     3,380       1,020       (916 )     7,000       (874 )
Total provision for credit losses for loans   $ 30,658     $ 29,166     $ 19,171     $ 81,068     $ 119,641  
Annualized ratio of total net charge-offs to total average loans     0.28 %     0.17 %     0.12 %     0.20 %     0.26 %
Allowance for credit losses for loans as a % of total loans     1.13 %     1.16 %     1.21 %     1.13 %     1.21 %

    As of
ASSET QUALITY:   September 30,   June 30,   March 31,   December 31,   September 30,
($ in thousands)     2026       2026       2026       2025       2025  
Accruing past due loans:                    
30 to 59 days past due:                    
Commercial and industrial   $ 6,990     $ 5,083     $ 5,285     $ 11,177     $ 912  
Commercial real estate     72,568       106,034       69,494       72,810       26,371  
Construction     —       1,752       —       —       —  
Residential mortgage     14,221       22,154       20,534       21,615       23,556  
Total consumer     15,488       15,974       13,112       14,420       12,728  
Total 30 to 59 days past due     109,267       150,997       108,425       120,022       63,567  
60 to 89 days past due:                    
Commercial and industrial     990       2,748       1,015       1,274       1,061  
Commercial real estate     10,869       —       —       —       6,033  
Residential mortgage     11,927       6,495       4,285       10,181       5,040  
Total consumer     4,127       3,904       3,506       5,269       4,023  
Total 60 to 89 days past due     27,913       13,147       8,806       16,724       16,157  
90 or more days past due:                    
Commercial and industrial     2,505       3,527       3,499       —       —  
Commercial real estate     10,295       5,454       —       212       —  
Residential mortgage     2,524       5,223       5,894       3,300       3,911  
Total consumer     2,008       1,862       1,309       1,070       1,125  
Total 90 or more days past due     17,332       16,066       10,702       4,582       5,036  
Total accruing past due loans   $ 154,512     $ 180,210     $ 127,933     $ 141,328     $ 84,760  
Non-accrual loans:                    
Commercial and industrial   $ 168,080     $ 147,731     $ 145,804     $ 138,321     $ 92,214  
Commercial real estate     253,088       256,081       225,417       236,221       235,754  
Construction     39,257       9,139       9,148       9,140       48,248  
Residential mortgage     44,858       42,992       45,988       44,424       38,949  
Total consumer     6,107       6,686       6,289       5,832       6,324  
Total non-accrual loans     511,390       462,629       432,646       433,938       421,489  
Other real estate owned (OREO)     1,729       4,126       5,161       4,531       4,783  
Other repossessed assets     675       1,020       1,758       1,286       1,065  
Total non-performing assets   $ 513,794     $ 467,775     $ 439,565     $ 439,755     $ 427,337  
Total non-accrual loans as a % of loans     0.96 %     0.88 %     0.85 %     0.87 %     0.86 %
Total accruing past due and non-accrual loans as a % of loans     1.25 %     1.23 %     1.10 %     1.15 %     1.03 %
Allowance for losses on loans as a % of non-accrual loans     113.57 %     127.66 %     135.10 %     134.44 %     138.79 %

NOTES TO SELECTED FINANCIAL DATA
     
(1 ) Net interest income and net interest margin are presented on a tax equivalent basis using a 21 percent federal tax rate. Valley believes that this presentation provides comparability of net interest income and net interest margin arising from both taxable and tax-exempt sources and is consistent with industry practice and SEC rules.
(2 ) Non-GAAP Reconciliations. This press release contains certain supplemental financial information, described in the Notes below, which has been determined by methods other than U.S. Generally Accepted Accounting Principles (“GAAP”) that management uses in its analysis of Valley’s performance. The Company believes that the non-GAAP financial measures provide useful supplemental information to both management and investors in understanding Valley’s underlying operational performance, business and performance trends, and may facilitate comparisons of our current and prior performance with the performance of others in the financial services industry. Management utilizes these measures for internal planning, forecasting and analysis purposes. Management believes that Valley’s presentation and discussion of this supplemental information, together with the accompanying reconciliations to the GAAP financial measures, also allows investors to view performance in a manner similar to management. These non-GAAP financial measures should not be considered in isolation or as a substitute for or superior to financial measures calculated in accordance with U.S. GAAP. These non-GAAP financial measures may also be calculated differently from similar measures disclosed by other companies.

Non-GAAP Reconciliations to GAAP Financial Measures

    Three Months Ended   Nine Months Ended
    September 30,   June 30,   September 30,   September 30,
($ in thousands, except for share data)     2026       2026       2025       2026       2025  
Adjusted net income available to common shareholders (non-GAAP):                    
Net income, as reported (GAAP)   $ 206,300     $ 170,885     $ 163,355     $ 541,098     $ 402,580  
Add: Merger related expenses (a)     3,094       —       —       3,094       —  
Add: Restructuring charge (b)     —       2,513       3,854       8,202       4,654  
Add: Litigation reserve (c)     —       230       1,012       1,492       1,012  
Add: Loss on extinguishment of debt     —       —       —       —       922  
Less: Litigation settlements (d)     (3,051 )     —       —       (3,051 )     —  
Less: (Gains) losses on available for sale and held to maturity debt securities, net (e)     (3 )     —       (28 )     7       (17 )
Less: FDIC special assessment (f)     —       —       (3,817 )     —       (3,817 )
Total non-GAAP adjustments to net income     40       2,743       1,021       9,744       2,754  
Income tax adjustments related to non-GAAP adjustments (g)     26       (782 )     (288 )     (2,740 )     (765 )
Net income, as adjusted (non-GAAP)   $ 206,366     $ 172,846     $ 164,088     $ 548,102     $ 404,569  
Dividends on preferred stock     7,335       7,316       7,644       21,868       21,547  
Net income available to common shareholders, as adjusted (non-GAAP)   $ 199,031     $ 165,530     $ 156,444     $ 526,234     $ 383,022  
__________                    
(a) Merger related expenses primarily include professional and legal fees and other expense.
(b) Represents severance expense related to workforce reductions within salary and employee benefits expense.
(c) Represents the change in legal reserves and settlement charges included in professional and legal fees.
(d) Represents recoveries from legal settlements included in other income.
(e) Included in gains on securities transactions, net.
(f) Represents the change in estimated special assessment losses included in the FDIC insurance assessment expense.
(g) Calculated using the appropriate blended statutory tax rate for the applicable period.
Adjusted per common share data (non-GAAP):                    
Net income available to common shareholders, as adjusted (non-GAAP)   $ 199,031     $ 165,530     $ 156,444     $ 526,234     $ 383,022  
Weighted average number of shares outstanding     552,358,147       553,740,562       560,504,275       553,946,293       560,154,649  
Basic earnings, as adjusted (non-GAAP)   $ 0.36     $ 0.30     $ 0.28     $ 0.95     $ 0.68  
Weighted average number of diluted shares outstanding     556,266,986       556,958,049       563,636,933       557,405,979       563,905,535  
Diluted earnings, as adjusted (non-GAAP)   $ 0.36     $ 0.30     $ 0.28     $ 0.94     $ 0.68  

    Three Months Ended   Nine Months Ended
    September 30,   June 30,   September 30,   September 30,
($ in thousands, except for share data)     2026       2026       2025       2026       2025  
Adjusted annualized return on average tangible common shareholders’ equity (non-GAAP):                    
Net income available to common shareholders, as adjusted (non-GAAP)   $ 199,031     $ 165,530     $ 156,444     $ 526,234     $ 383,022  
Add: Amortization of other intangible assets (net of tax), other than loan servicing rights     4,239       4,247       5,112       13,232       15,851  
Net income available to common shareholders excluding intangible amortization, as adjusted (non-GAAP)     203,270       169,777       161,556       539,466       398,873  
Average shareholders’ equity     7,967,868       7,901,688       7,616,810       7,908,818       7,533,660  
Less: Average preferred shareholders equity     354,345       354,345       354,345       354,345       354,345  
Less: Average goodwill (net of deferred tax liability)     1,858,851       1,858,851       1,859,614       1,858,851       1,859,614  
Less: Average intangible assets (net of deferred tax liability), other than loan servicing rights     46,027       51,387       62,905       51,457       69,431  
Average tangible common shareholders’ equity   $ 5,708,645     $ 5,637,105     $ 5,339,946     $ 5,644,165     $ 5,250,270  
Annualized return on average tangible common shareholders’ equity, as adjusted (non-GAAP)     14.24 %     12.05 %     12.10 %     12.74 %     10.13 %
Adjusted annualized return on average assets (non-GAAP):                    
Net income, as adjusted (non-GAAP)   $ 206,366     $ 172,846     $ 164,088     $ 548,102     $ 404,569  
Average assets   $ 66,506,401     $ 65,584,823     $ 63,046,215     $ 65,435,632     $ 62,224,382  
Annualized return on average assets, as adjusted (non-GAAP)     1.24 %     1.05 %     1.04 %     1.12 %     0.87 %
Adjusted annualized return on average shareholders’ equity (non-GAAP):                    
Net income, as adjusted (non-GAAP)   $ 206,366     $ 172,846     $ 164,088     $ 548,102     $ 404,569  
Average shareholders’ equity   $ 7,967,868     $ 7,901,688     $ 7,616,810     $ 7,908,818     $ 7,533,660  
Annualized return on average shareholders’ equity, as adjusted (non-GAAP)     10.36 %     8.75 %     8.62 %     9.24 %     7.16 %
Annualized return on average tangible common shareholders’ equity (non-GAAP):                    
Net income available to common shareholders   $ 198,965     $ 163,569     $ 155,711     $ 519,230     $ 381,033  
Add: Amortization of other intangible assets (net of tax), other than loan servicing rights     4,239       4,247       5,112       13,232       15,851  
Net income available to common shareholders excluding intangible amortization (non-GAAP)     203,204       167,816       160,823       532,462       396,884  
Average tangible common shareholders’ equity (non-GAAP)   $ 5,708,645     $ 5,637,105     $ 5,339,946     $ 5,644,165     $ 5,250,270  
Annualized return on average tangible common shareholders’ equity (non-GAAP)     14.24 %     11.91 %     12.05 %     12.58 %     10.08 %
                     
Efficiency ratio (non-GAAP):                    
Non-interest expense, as reported (GAAP)   $ 309,958     $ 311,123     $ 281,985     $ 931,007     $ 842,725  
Less: Merger related expenses (pre-tax)     3,094       —       —       3,094       —  
Less: Amortization of tax credit investments (pre-tax)     19,904       16,157       8,147       52,075       26,601  
Less: Restructuring charge (pre-tax)     —       2,513       3,854       8,202       4,654  
Less: Litigation reserve (pre-tax)     —       230       1,012       1,492       1,012  
Less: Loss on extinguishment of debt (pre-tax)     —       —       —       —       922  
Add: FDIC special assessment (pre-tax)     —       —       (3,817 )     —       (3,817 )
Non-interest expense, as adjusted (non-GAAP)     286,960       292,223       272,789       866,144       813,353  
Net interest income, as reported (GAAP)     505,451       487,024       446,224       1,464,000       1,298,737  
Non-interest income, as reported (GAAP)     78,700       73,711       64,887       221,247       185,785  
Less: (Gains) losses on available for sale and held to maturity securities transactions, net (pre-tax)     (3 )     —       (28 )     7       (17 )
Less: Litigation settlements (pre-tax)     (3,051 )     —       —       (3,051 )     —  
Gross operating income, as adjusted (non-GAAP)   $ 581,097     $ 560,735     $ 511,083     $ 1,682,203     $ 1,484,505  
Efficiency ratio (non-GAAP)     49.38 %     52.11 %     53.37 %     51.49 %     54.79 %

    As of
    September 30,   June 30,   March 31,   December 31,   September 30,
($ in thousands, except for share data)     2026       2026       2026       2025       2025  
Tangible book value per common share (non-GAAP):                    
Common shares outstanding     550,621,196       553,069,100       554,316,876       556,618,021       560,784,352  
Shareholders’ equity (GAAP)   $ 7,896,552     $ 7,917,144     $ 7,828,443     $ 7,807,698     $ 7,695,374  
Less: Preferred stock     354,345       354,345       354,345       354,345       354,345  
Less: Goodwill and other intangible assets     1,952,392       1,958,135       1,963,706       1,969,811       1,976,594  
Tangible common shareholders’ equity (non-GAAP)   $ 5,589,815     $ 5,604,664     $ 5,510,392     $ 5,483,542     $ 5,364,435  
Tangible book value per common share (non-GAAP)   $ 10.15     $ 10.13     $ 9.94     $ 9.85     $ 9.57  
Tangible common equity to tangible assets (non-GAAP):                    
Tangible common shareholders’ equity (non-GAAP)   $ 5,589,815     $ 5,604,664     $ 5,510,392     $ 5,483,542     $ 5,364,435  
Total assets (GAAP)     67,470,879       66,318,308       64,466,585       64,132,725       63,018,614  
Less: Goodwill and other intangible assets     1,952,392       1,958,135       1,963,706       1,969,811       1,976,594  
Tangible assets (non-GAAP)   $ 65,518,487     $ 64,360,173     $ 62,502,879     $ 62,162,914     $ 61,042,020  
Tangible common equity to tangible assets (non-GAAP)     8.53 %     8.71 %     8.82 %     8.82 %     8.79 %

VALLEY NATIONAL BANCORP
CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION
(in thousands, except for share data)

    September 30,   December 31,
      2026       2025  
    (Unaudited)    
Assets        
Cash and due from banks   $ 339,682     $ 315,166  
Interest bearing deposits with banks     785,320       1,268,399  
Investment securities:        
Equity securities     92,700       82,774  
Trading debt securities     26,749       —  
Available for sale debt securities     4,229,810       4,202,218  
Held to maturity debt securities (net of allowance for credit losses of $727 at September 30, 2026 and $734 at December 31, 2025)     3,726,695       3,495,837  
Total investment securities     8,075,954       7,780,829  
Loans held for sale (includes fair value of $7,452 at September 30, 2026 and $8,212 at December 31, 2025 for loans originated for sale)     16,202       26,236  
Loans     53,189,984       50,136,728  
Less: Allowance for loan losses     (580,800 )     (583,400 )
Net loans     52,609,184       49,553,328  
Premises and equipment, net     311,548       330,757  
Lease right of use assets     292,927       313,891  
Bank owned life insurance     743,687       738,090  
Accrued interest receivable     259,987       243,897  
Goodwill     1,868,936       1,868,936  
Other intangible assets, net     83,456       100,875  
Other assets     2,083,996       1,592,321  
Total Assets   $ 67,470,879     $ 64,132,725  
Liabilities        
Deposits:        
Non-interest bearing   $ 12,446,761     $ 12,155,500  
Interest bearing:        
Savings, NOW and money market     29,397,309       28,603,470  
Time     13,384,725       11,424,123  
Total deposits     55,228,795       52,183,093  
Short-term borrowings     50,256       91,475  
Long-term borrowings     2,607,639       2,908,579  
Junior subordinated debentures issued to capital trusts     58,064       57,803  
Lease liabilities     348,505       372,448  
Accrued expenses and other liabilities     1,281,068       711,629  
Total Liabilities     59,574,327       56,325,027  
Shareholders’ Equity        
Preferred stock, no par value; 50,000,000 authorized shares:        
Series A (4,600,000 shares issued at September 30, 2026 and December 31, 2025)     111,590       111,590  
Series B (4,000,000 shares issued at September 30, 2026 and December 31, 2025)     98,101       98,101  
Series C (6,000,000 shares issued at September 30, 2026 and December 31, 2025)     144,654       144,654  
Common stock (no par value, authorized 650,000,000 shares; issued 560,878,750 shares at September 30, 2026 and December 31, 2025)     196,730       196,730  
Surplus     5,467,999       5,464,845  
Retained earnings     2,241,005       1,912,933  
Accumulated other comprehensive loss     (232,186 )     (74,379 )
Treasury stock, at cost (10,257,554 common shares at September 30, 2026 and 4,260,729 common shares at December 31, 2025)     (131,341 )     (46,776 )
Total Shareholders’ Equity     7,896,552       7,807,698  
Total Liabilities and Shareholders’ Equity   $ 67,470,879     $ 64,132,725  

VALLEY NATIONAL BANCORP
CONSOLIDATED STATEMENTS OF INCOME (Unaudited)
(in thousands, except for share data)

    Three Months Ended
  Nine Months Ended
    September 30,   June 30,   September 30,
  September 30,
      2026       2026       2025       2026       2025  
Interest Income                      
Interest and fees on loans   $ 764,546     $ 736,060     $ 733,191     $ 2,209,246     $ 2,157,082  
Interest and dividends on investment securities:                      
Taxable     78,028       76,113       70,211       227,949       201,273  
Tax-exempt     4,969       5,048       4,611       14,735       13,994  
Dividends     4,474       5,771       4,891       15,045       16,083  
Interest on federal funds sold and other short-term investments     5,182       6,383       14,019       22,323       28,255  
Total interest income     857,199       829,375       826,923       2,489,298       2,416,687  
Interest Expense                      
Interest on deposits:                      
Savings, NOW and money market     196,272       190,973       210,921       578,030       614,532  
Time     119,337       112,693       133,108       338,708       387,501  
Interest on short-term borrowings     3,322       6,047       555       9,605       5,237  
Interest on long-term borrowings and junior subordinated debentures     32,817       32,638       36,115       98,955       110,680  
Total interest expense     351,748       342,351       380,699       1,025,298       1,117,950  
Net Interest Income     505,451       487,024       446,224       1,464,000       1,298,737  
(Credit) provision for credit losses for available for sale and held to maturity securities     (17 )     (2 )     —       (7 )     (10 )
Provision for credit losses for loans     30,658       29,166       19,171       81,068       119,641  
Net Interest Income After Provision for Credit Losses     474,810       457,860       427,053       1,382,939       1,179,106  
Non-Interest Income                      
Wealth management and trust fees     22,178       17,655       16,134       55,839       45,221  
Insurance commissions     3,015       3,770       2,914       9,652       9,746  
Capital markets     9,996       12,933       9,814       33,310       26,521  
Service charges on deposit accounts     19,156       18,728       16,764       56,088       44,195  
Gains on securities transactions, net     259       50       28       330       73  
Fees from loan servicing     3,089       3,268       3,405       9,575       10,291  
Gains on sales of loans, net     1,254       1,742       740       6,086       4,962  
Bank owned life insurance     3,675       5,913       4,657       15,423       15,453  
Other     16,078       9,652       10,431       34,944       29,323  
Total non-interest income     78,700       73,711       64,887       221,247       185,785  
Non-Interest Expense                      
Salary and employee benefits expense     150,080       150,432       146,820       456,227       434,860  
Net occupancy expense     25,727       27,179       24,865       80,088       76,236  
Technology, furniture and equipment expense     32,312       33,247       30,708       97,437       91,271  
FDIC insurance assessment     10,802       11,691       8,357       32,969       33,416  
Amortization of other intangible assets     6,319       6,268       7,544       19,506       22,990  
Professional and legal fees     25,125       29,533       24,261       79,800       59,901  
Loss on extinguishment of debt     —       —       —       —       922  
Amortization of tax credit investments     19,904       16,157       8,147       52,075       26,601  
Other     39,689       36,616       31,283       112,905       96,528  
Total non-interest expense     309,958       311,123       281,985       931,007       842,725  
Income Before Income Taxes     243,552       220,448       209,955       673,179       522,166  
Income tax expense     37,252       49,563       46,600       132,081       119,586  
Net Income     206,300       170,885       163,355       541,098       402,580  
Dividends on preferred stock     7,335       7,316       7,644       21,868       21,547  
Net Income Available to Common Shareholders   $ 198,965     $ 163,569     $ 155,711     $ 519,230     $ 381,033  

VALLEY NATIONAL BANCORP
Quarterly Analysis of Average Assets, Liabilities and Shareholders’ Equity and
Net Interest Income on a Tax Equivalent Basis

    Three Months Ended
    September 30, 2026   June 30, 2026   September 30, 2025
    Average       Avg.   Average       Avg.   Average       Avg.
($ in thousands)   Balance   Interest   Rate   Balance   Interest   Rate   Balance   Interest   Rate
Assets                                    
Interest earning assets:                                
Loans (1)(2)   $ 52,683,932   $ 764,568     5.80 %   $ 51,884,173   $ 736,082     5.67 %   $ 49,270,853   $ 733,214     5.95 %
Taxable investments (3)     8,048,596     82,502     4.10       7,928,555     81,884     4.13       7,522,290     75,102     3.99  
Tax-exempt investments (1)(3)     530,189     6,290     4.75       544,950     6,390     4.69       540,491     5,837     4.32  
Interest bearing deposits with banks     571,885     5,182     3.62       699,684     6,383     3.65       1,289,519     14,019     4.35  
Total interest earning assets     61,834,602     858,542     5.55       61,057,362     830,739     5.44       58,623,153     828,172     5.65  
Other assets     4,671,799             4,527,461             4,423,062        
Total assets   $ 66,506,401           $ 65,584,823           $ 63,046,215        
Liabilities and shareholders’ equity                                    
Interest bearing liabilities:                                    
Savings, NOW and money market deposits   $ 28,982,923   $ 196,272     2.71 %   $ 28,920,057   $ 190,973     2.64 %   $ 27,005,791   $ 210,921     3.12 %
Time deposits     12,529,463     119,337     3.81       11,881,270     112,693     3.79       12,621,182     133,108     4.22  
Short-term borrowings     373,156     3,322     3.56       674,094     6,047     3.59       89,147     555     2.49  
Long-term borrowings (4)     2,665,456     32,817     4.92       2,684,781     32,638     4.86       2,961,510     36,115     4.88  
Total interest bearing liabilities     44,550,998     351,748     3.16       44,160,202     342,351     3.10       42,677,630     380,699     3.57  
Non-interest bearing deposits     12,650,995             12,372,974             11,540,351        
Other liabilities     1,336,540             1,149,959             1,211,424        
Shareholders’ equity     7,967,868             7,901,688             7,616,810        
Total liabilities and shareholders’ equity   $ 66,506,401           $ 65,584,823           $ 63,046,215        
                                     
Net interest income/interest rate spread (5)       $ 506,794     2.39 %       $ 488,388     2.34 %       $ 447,473     2.08 %
Tax equivalent adjustment         (1,343 )             (1,364 )             (1,249 )    
Net interest income, as reported       $ 505,451             $ 487,024             $ 446,224      
Net interest margin (6)           3.27 %           3.19 %           3.04 %
Tax equivalent effect           0.01             0.01             0.01  
Net interest margin on a fully tax equivalent basis (6)           3.28 %           3.20 %           3.05 %
_____________________
(1) Interest income is presented on a tax equivalent basis using a 21 percent federal tax rate.
(2) Loans are stated net of unearned income and include non-accrual loans.
(3) The yield for securities that are classified as available for sale is based on the average historical amortized cost.
(4) Includes junior subordinated debentures issued to capital trusts which are presented separately on the consolidated statements of financial condition.
(5) Interest rate spread represents the difference between the average yield on interest earning assets and the average cost of interest bearing liabilities and is presented on a fully tax equivalent basis.
(6) Net interest income as a percentage of total average interest earning assets.

INVESTOR RELATIONS
Requests for copies of reports and/or other inquiries should be directed to Andrew Jianette, Investor Relations, Valley National Bancorp, 70 Speedwell Avenue, Morristown, New Jersey, 07960 or by e-mail at investorrelations@valley.com.

Contact:   Travis Lan
    Senior Executive Vice President and
    Chief Financial Officer
    973-686-5007

Q3 2026 Highlights:

  • Net sales increased 4% to $1.5 billion, accelerating from 2% growth in the second quarter, supported by price, solid maintenance growth and continued improvement in building materials
  • Operating income decreased 3% to $172.2 million from $178.0 million in Q3 2025
  • Diluted EPS consistent with Q3 2025 at $3.40; adjusted diluted EPS increased $0.01
  • Confirms annual earnings guidance range of $10.66 to $10.96 per diluted share, and adjusted diluted earnings guidance range of $10.87 to $11.17 per share including $0.02 of year-to-date ASU 2016-09 tax benefits

COVINGTON, La., Oct. 22, 2026 (GLOBE NEWSWIRE) — Pool Corporation (Nasdaq: POOL) today reported results for the third quarter of 2026.

“Building on our performance through the first half of the year, we delivered solid results in the third quarter of 2026 as we moved through the end of the peak selling season. Our dedicated teams produced top-line growth by delivering to our customers when they needed it the most. At the same time, we remained committed to disciplined capital allocation, reducing inventory by 3% while growing sales. Through the first nine months of the year, we generated $419.8 million in operating cash flows, and in the third quarter alone we returned $158.7 million to shareholders through share repurchases and dividends. As the industry leader, we are focused on supporting our partners to collectively grow the outdoor living industry, efficiently bringing new products to market and offering the best value proposition to our customers,” said John B. Watwood, president and CEO.

Third quarter ended September 30, 2026 compared to the third quarter ended September 30, 2025

Net sales increased 4% to $1.5 billion in the third quarter of 2026. The increase primarily reflected 3% growth from price, coupled with stronger maintenance activity and building materials growth.

Gross profit increased 2% to $436.3 million. Gross margin decreased 60 basis points to 29.0% from 29.6% in the same period of 2025. The decrease was primarily driven by higher inbound freight costs and customer mix, as well as the comparison against the prior year benefit from mid-season price increases.

Selling and administrative expenses (operating expenses) increased 5% to $264.1 million from $251.2 million in the same period in 2025, reflecting higher performance-based compensation resulting from increased sales, increases in employee insurance and outside fees related to our strategic initiatives.

Operating income decreased 3% to $172.2 million compared to $178.0 million in the same period last year.

Net income decreased 3% to $123.0 million from $127.0 million in the third quarter of 2025.

Earnings per diluted share was $3.40, consistent with the third quarter of 2025. Adjusting for the impact from Accounting Standards Update (ASU) 2016-09, Improvements to Employee Share-Based Payment Accounting, earnings per diluted share was $3.40 in the third quarter of 2026 compared to $3.39 in the same period of 2025.

Nine months ended September 30, 2026 compared to the nine months ended September 30, 2025

Net sales increased 4% to $4.5 billion from $4.3 billion in the nine months ended September 30, 2025. Gross margin declined 30 basis points to 29.3% from 29.6% in the same period last year. 

Operating expenses increased 5% to $784.5 million compared to $748.5 million for the same period in 2025. Operating expenses for the nine months ended September 30, 2026 included $8.3 million of CEO transition costs, comprised of $6.3 million of non-cash share-based compensation expense for awards previously granted but not fully amortized and $2.0 million of cash transition costs. Adjusting for the impact of CEO transition costs, operating expenses increased 4%.

Operating income was $522.5 million compared to $528.2 million in the same period last year. Adjusted operating income was $530.7 million, in line with the same period of 2025.

Net income decreased 3% to $364.4 million compared to $374.8 million in the nine months ended September 30, 2025. We recorded a $0.7 million, or $0.02 per diluted share, tax benefit from ASU 2016-09 in 2026 compared to a $4.2 million, or $0.11 per diluted share, tax benefit in the same period of 2025. Adjusted net income for the nine months ended September 30, 2026 was $371.2 million compared to $370.6 million in the nine months ended September 30, 2025.

Earnings per diluted share increased 1% to $10.02 compared to $9.97 in the same period of 2025. Adjusted earnings per diluted share increased 4% to $10.21 from $9.86 in the first nine months of 2025.

Balance Sheet and Liquidity

Inventory decreased 3% at September 30, 2026 compared to September 30, 2025, while third quarter net sales increased 4% year over year. Total debt outstanding increased $104.9 million to $1.2 billion at September 30, 2026.

Net cash provided by operations increased 47% to $419.8 million in the first nine months of 2026 compared to $285.7 million in the first nine months of 2025. Year to date, we have returned $338.1 million to our shareholders through $140.1 million in dividends and $198.0 million in share repurchases. These returns were primarily funded by operating cash flows, after investing $49.8 million in the business and making $33.1 million in net debt repayments. We have also increased our quarterly dividend by 4% to $1.30 per share from $1.25 per share in the third quarter of 2025.

Outlook

“Based on our performance to date and outlook for the remainder of the year, we are confirming our full-year adjusted diluted EPS guidance range of $10.87 to $11.17. As we look forward to closing out 2026, I am proud of the POOLCORP team, whose dedication and execution are the true source of our success. Our unmatched network, solid operational performance and strong supplier relationships position us well to continue delivering exceptional value to our customers and the outdoor living industry,” said Watwood.

The table below further illustrates our current guidance:

(Unaudited)   2026 Guidance Range  
    Floor   Ceiling  
Diluted EPS(1)   $ 10.66   $ 10.96  
After-tax CEO transition costs     0.21     0.21  
Adjusted diluted EPS(1)   $ 10.87   $ 11.17  
               

(1)    Includes $0.02 of year-to-date ASU 2016-09 tax benefits.

Non-GAAP Financial Measures

This press release contains certain non-GAAP measures. See the addendum to this release for definitions of our non-GAAP measures and reconciliations of our non-GAAP measures to GAAP measures.

About Pool Corporation

POOLCORP is the world’s largest wholesale distributor of swimming pool and related backyard products. As of September 30, 2026, POOLCORP operated 454 sales centers in North America, Europe and Australia, through which it distributes more than 200,000 products to roughly 125,000 wholesale customers. For more information, please visit www.poolcorp.com.

Forward-Looking Statements

This news release includes “forward-looking” statements that involve risks and uncertainties that are generally identifiable through the use of words such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” “project,” “should,” “will,” “may,” “outlook,” and other words and similar expressions and include projections of earnings. The forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date of this release, and we undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur. Actual results may differ materially due to a variety of factors, including the sensitivity of our business to weather conditions; changes in economic conditions, consumer discretionary spending, the housing market, inflation or interest rates; our ability to maintain favorable relationships with suppliers and manufacturers; competition from other leisure product alternatives or mass merchants; our ability to continue to execute our growth strategies; changes in the regulatory environment; new or additional taxes, duties or tariffs; excess tax benefits or deficiencies recognized under ASU 2016-09 and other risks detailed in POOLCORP’s 2025 Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports and filings filed with the Securities and Exchange Commission (SEC) as updated by POOLCORP’s subsequent filings with the SEC.

Kristin S. Byars
Director, Investor Relations and Finance
985.801.5153
kristin.byars@poolcorp.com

POOL CORPORATION
Consolidated Statements of Income
(Unaudited)
(In thousands, except per share data)
 
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2026     2025     2026     2025  
Net sales   $ 1,504,957     $ 1,451,131     $ 4,465,909     $ 4,307,187  
Cost of sales     1,068,640       1,021,948       3,158,959       3,030,474  
Gross profit     436,317       429,183       1,306,950       1,276,713  
Percent     29.0 %     29.6 %     29.3 %     29.6 %
                         
Selling and administrative expenses     264,122       251,196       784,464       748,518  
Operating income     172,195       177,987       522,486       528,195  
Percent     11.4 %     12.3 %     11.7 %     12.3 %
                         
Interest and other non-operating expenses, net     11,762       12,004       38,402       35,387  
Income before income taxes and equity in earnings     160,433       165,983       484,084       492,808  
Provision for income taxes     37,449       38,985       119,774       118,048  
Equity in earnings of unconsolidated investments, net     58       15       51       56  
Net income   $ 123,042     $ 127,013     $ 364,361     $ 374,816  
                         
Earnings per share attributable to common stockholders (1)                        
Basic   $ 3.41     $ 3.41     $ 10.03     $ 10.01  
Diluted   $ 3.40     $ 3.40     $ 10.02     $ 9.97  
Weighted average common shares outstanding:                        
Basic     35,881       37,090       36,108       37,272  
Diluted     35,923       37,223       36,163       37,420  
                         
Cash dividends declared per common share   $ 1.30     $ 1.25     $ 3.85     $ 3.70  

 (1)   Earnings per share under the two-class method is calculated using net income attributable to common stockholders (net income reduced by earnings allocated to participating securities), which was $122.3 million and $126.4 million for the three months ended September 30, 2026 and September 30, 2025, respectively, and $362.3 million and $373.0 million for the nine months ended September 30, 2026 and September 30, 2025, respectively. Participating securities excluded from weighted average common shares outstanding were 216,000 and 184,000 for the three months ended September 30, 2026 and September 30, 2025, respectively, and 206,000 and 184,000 for the nine months ended September 30, 2026 and September 30, 2025, respectively. 

POOL CORPORATION
Condensed Consolidated Balance Sheets
(Unaudited)
(In thousands)
 
    September 30,     September 30,     Change
    2026     2025     $   %
                         
Assets                        
Current assets:                        
Cash and cash equivalents   $ 105,657     $ 128,483     $ (22,826 )   (18 ) %
Receivables, net (1)     135,492       138,072       (2,580 )   (2 )  
Receivables pledged under receivables facility     342,965       305,537       37,428     12    
Product inventories, net (2)     1,185,177       1,223,809       (38,632 )   (3 )  
Prepaid expenses and other current assets     52,365       53,138       (773 )   (1 )  
Total current assets     1,821,656       1,849,039       (27,383 )   (1 )  
                         
Property and equipment, net     281,030       267,408       13,622     5    
Goodwill     706,683       705,266       1,417     0    
Other intangible assets, net     277,972       285,409       (7,437 )   (3 )  
Equity interest investments     1,645       1,514       131     9    
Operating lease assets     342,895       319,898       22,997     7    
Other assets     53,588       72,137       (18,549 )   (26 )  
Total assets   $ 3,485,469     $ 3,500,671     $ (15,202 )   (0 ) %
                         
Liabilities and stockholders’ equity                        
Current liabilities:                        
Accounts payable   $ 423,865     $ 457,319     $ (33,454 )   (7 )  
Accrued expenses and other current liabilities     174,146       147,122       27,024     18    
Short-term borrowings and current portion of long-term debt     20,952       12,881       8,071     63    
Current operating lease liabilities     120,756       102,189       18,567     18    
Total current liabilities     739,719       719,511       20,208     3    
                         
Deferred income taxes     93,984       79,101       14,883     19    
Long-term debt, net     1,145,930       1,049,121       96,809     9    
Other long-term liabilities     47,620       47,342       278     1    
Non-current operating lease liabilities     231,098       225,706       5,392     2    
Total liabilities     2,258,351       2,120,781       137,570     6    
Total stockholders’ equity     1,227,118       1,379,890       (152,772 )   (11 )  
Total liabilities and stockholders’ equity   $ 3,485,469     $ 3,500,671     $ (15,202 )   (0 ) %

(1)   The allowance for doubtful accounts was $10.3 million at September 30, 2026 and $8.3 million at September 30, 2025.
     
(2)   The inventory reserve was $24.9 million at September 30, 2026 and $29.0 million at September 30, 2025.

POOL CORPORATION
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(In thousands)
 
    Nine Months Ended        
    September 30,        
    2026     2025     Change  
Operating activities                  
Net income   $ 364,361     $ 374,816     $ (10,455 )
Adjustments to reconcile net income to net cash provided by operating activities:                  
Depreciation     34,461       30,438       4,023  
Amortization     6,750       6,598       152  
Share-based compensation     22,437       17,385       5,052  
Equity in earnings of unconsolidated investments, net     (51 )     (56 )     5  
Other     3,489       459       3,030  
Changes in operating assets and liabilities, net of effects of acquisitions:                  
Receivables     (134,083 )     (123,914 )     (10,169 )
Product inventories     264,883       77,407       187,476  
Prepaid expenses and other assets     19,765       73,226       (53,461 )
Accounts payable     (225,440 )     (69,794 )     (155,646 )
Accrued expenses and other liabilities     63,252       (100,822 )     164,074  
Net cash provided by operating activities     419,824       285,743       134,081  
                   
Investing activities                  
Acquisition of businesses, net of cash acquired     —       (7,116 )     7,116  
Purchases of property and equipment, net of sale proceeds     (49,772 )     (48,123 )     (1,649 )
Other investments, net     2,328       (508 )     2,836  
Net cash used in investing activities     (47,444 )     (55,747 )     8,303  
                   
Financing activities                  
Proceeds from revolving line of credit     1,351,300       1,417,100       (65,800 )
Payments on revolving line of credit     (1,496,400 )     (1,390,400 )     (106,000 )
Proceeds from term loan under credit facility     —       125,000       (125,000 )
Payments on term loan under credit facility     —       (87,500 )     87,500  
Proceeds from asset-backed financing     390,300       437,600       (47,300 )
Payments on asset-backed financing     (278,800 )     (370,400 )     91,600  
Payments on term facility     —       (19,938 )     19,938  
Proceeds from short-term borrowings and current portion of long-term debt     7,103       17,431       (10,328 )
Payments on short-term borrowings and current portion of long-term debt     (6,555 )     (16,523 )     9,968  
Payments of deferred financing costs     (359 )     (1,397 )     1,038  
Payments of excise tax on repurchases of common stock     (2,974 )     —       (2,974 )
Proceeds from stock issued under share-based compensation plans     5,018       9,203       (4,185 )
Payments of cash dividends     (140,105 )     (138,664 )     (1,441 )
Repurchases of common stock     (198,046 )     (163,884 )     (34,162 )
Net cash used in financing activities     (369,518 )     (182,372 )     (187,146 )
Effect of exchange rate changes on cash and cash equivalents     (2,168 )     2,997       (5,165 )
Change in cash and cash equivalents     694       50,621       (49,927 )
Cash and cash equivalents at beginning of period     104,963       77,862       27,101  
Cash and cash equivalents at end of period   $ 105,657     $ 128,483     $ (22,826 )
                         

ADDENDUM

Base Business

When calculating our base business results, we exclude for a period of 15 months sales centers that are acquired, opened in new markets or closed. We also exclude consolidated sales centers when we do not expect to maintain the majority of the existing business and existing sales centers that are consolidated with acquired sales centers.

We generally allocate corporate overhead expenses to excluded sales centers on the basis of their net sales as a percentage of total net sales. After 15 months, we include acquired, consolidated and new market sales centers in the base business calculation including the comparative prior year period.

We have not provided separate base business income statement data within this press release as our base business results for the three and nine months ended September 30, 2026 closely approximated our consolidated results. Excluded sales centers contributed less than 1% to the change in our reported net sales.

The table below summarizes the changes in our sales centers during the first nine months of 2026.

December 31, 2025 456
New locations 2
Consolidated locations (4)
September 30, 2026 454
   

Reconciliation of Non-GAAP Financial Measures

The non-GAAP measures described below should be considered in the context of all of our other disclosures in this press release.

Adjusted EBITDA

We define Adjusted EBITDA as net income or net loss plus interest and other non-operating expenses, provision for income taxes, depreciation, amortization, share-based compensation, goodwill and other impairments, equity in earnings or loss of unconsolidated investments, and other items that management believes are not indicative of ongoing operating performance. Other companies may calculate Adjusted EBITDA differently than we do, which may limit its usefulness as a comparative measure.

Adjusted EBITDA is not a measure of performance as determined by generally accepted accounting principles (GAAP). We believe Adjusted EBITDA should be considered in addition to, not as a substitute for, operating income or loss, net income or loss, net cash flows provided by or used in operating, investing and financing activities or other income statement or cash flow statement line items reported in accordance with GAAP.

From time to time, we use Adjusted EBITDA as a supplemental disclosure because management uses it to monitor our performance, and we believe that it is widely used by our investors, industry analysts and others as a useful supplemental performance measure. We believe that Adjusted EBITDA, when viewed with our GAAP results and the accompanying reconciliations, provides an additional measure that enables management and investors to monitor factors and trends affecting our ability to service debt, pay taxes and fund capital expenditures.
   
The table below presents a reconciliation of net income to Adjusted EBITDA.

(Unaudited)   Three Months Ended     Nine Months Ended  
(In thousands)   September 30,     September 30,  
    2026     2025     2026     2025  
Net income   $ 123,042     $ 127,013     $ 364,361     $ 374,816  
Adjustments to increase (decrease) net income:                        
Interest and other non-operating expenses (1)     11,415       11,622       37,846       35,633  
Provision for income taxes     37,449       38,985       119,774       118,048  
Share-based compensation (2)     4,962       4,435       22,437       17,385  
Equity in earnings of unconsolidated investments, net     (58 )     (15 )     (51 )     (56 )
Depreciation     11,807       10,634       34,461       30,438  
Amortization (3)     1,917       2,000       5,910       5,925  
CEO cash transition costs (2)     —       —       1,962       —  
Adjusted EBITDA   $ 190,534     $ 194,674     $ 586,700     $ 582,189  

(1)   Excludes loss (gain) on foreign currency transactions of $347 and $382 for the three months ended September 30, 2026 and September 30, 2025, respectively, and $556 and ($246) for the nine months ended September 30, 2026 and September 30, 2025, respectively.
     
(2)   CEO transition costs comprise $6.3 million included within share-based compensation for awards previously granted but not fully amortized and $2.0 million of cash transition costs for a total of $8.3 million included in Selling and administrative expenses on the Consolidated Statements of Income for the nine months ended September 30, 2026.
     
(3)   Excludes amortization of deferred financing costs of $290 and $286 for the three months ended September 30, 2026 and September 30, 2025, respectively, and $840 and $673 for the nine months ended September 30, 2026 and September 30, 2025, respectively. This non-cash expense is included in Interest and other non-operating expenses, net on the Consolidated Statements of Income.
     

Adjusted Income Statement Information

We have included adjusted operating expenses, adjusted operating income, adjusted net income and adjusted diluted EPS, which are non-GAAP financial measures, in this press release as supplemental disclosures because we believe these measures are useful to management, investors and others in assessing our period-over-period operating performance. We believe these measures should be considered in addition to, not as a substitute for, operating expenses, operating income, net income and diluted EPS presented in accordance with GAAP and in the context of our other disclosures in this press release. Other companies may calculate these non-GAAP financial measures differently than we do, which may limit their usefulness as comparative measures.

The table below presents a reconciliation of operating expenses to adjusted operating expenses.

(Unaudited)   Nine Months Ended  
(In thousands)   September 30,  
    2026  
Operating expenses   $ 784,464  
CEO transition costs     (8,262 )
Adjusted operating expenses   $ 776,202  
         

The table below presents a reconciliation of operating income to adjusted operating income.

(Unaudited)   Nine Months Ended  
(In thousands)   September 30,  
    2026  
Operating income   $ 522,486  
CEO transition costs     8,262  
Adjusted operating income   $ 530,748  
         

The table below presents a reconciliation of net income to adjusted net income.

(Unaudited)   Nine Months Ended  
(In thousands)   September 30,  
    2026   2025  
Net income   $ 364,361   $ 374,816  
CEO transition costs     8,262     —  
Tax impact     (738 )   —  
ASU 2016-09 tax benefit     (714 )   (4,181 )
Adjusted net income   $ 371,171   $ 370,635  
               

The table below presents a reconciliation of diluted EPS to adjusted diluted EPS.

(Unaudited)   Three Months Ended   Nine Months Ended  
    September 30,   September 30,  
    2026   2025   2026   2025  
Diluted EPS   $ 3.40   $ 3.40   $ 10.02   $ 9.97  
After-tax CEO transition costs     —     —     0.21     —  
ASU 2016-09 tax benefit     —     (0.01 )   (0.02 )   (0.11 )
Adjusted diluted EPS   $ 3.40   $ 3.39   $ 10.21   $ 9.86  

SOMERVILLE, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) — Generate Biomedicines Inc. (Nasdaq: GENB) (“Generate”) today announced that members of its management team will participate in presentations at the following investor conferences:

  • Guggenheim 3rd Annual Healthcare Innovation Conference, Boston, Massachusetts: Monday, Nov. 9 at 1 p.m. ET
  • Jefferies Global Healthcare Conference, London, UK: Monday, Nov. 16 at 10:30 a.m. ET

To access live webcasts of Generate’s presentations, please visit the “Events & Presentations” page within the Investors section of Generate’s website at https://investors.generatebiomedicines.com. A replay of the webcasts will be available on Generate’s website for 90 days following the event.

About Generate Biomedicines Inc.
Generate (Nasdaq: GENB) is a clinical-stage generative biology company founded at the intersection of machine learning, biological engineering, and medicine, advancing a new era of programmable biology to engineer better drug candidates for patients, faster. The Generate Platform integrates computational design with large-scale biological experimentation, enabling the creation of novel, optimized therapeutics that address historically undruggable and hard-to-drug targets, as well as known targets in new and more effective ways. The platform has enabled the generation of a broad pipeline across multiple therapeutic areas and protein-based modalities, addressing health challenges out of reach of traditional approaches. Founded in 2018, Generate is leading a fundamental shift from drug discovery to drug generation. Learn more at www.generatebiomedicines.com or follow us on X, LinkedIn, and YouTube.

Digital Media Disclosure
From time to time Generate has used, or expects in the future to use, its investor website (investors.generatebiomedicines.com), the Generate LinkedIn account (linkedin.com/company/generate-biomedicines), and the Generate X account (@generate_biomed) as means of disclosing information to the public in a broad, nonexclusionary manner, including for purposes of the SEC’s Regulation Fair Disclosure (Reg FD). Accordingly, investors should monitor the investor website and these social media channels in addition to news releases, SEC filings, public conference calls, and webcasts, as the information posted on them could be material to investors.

Cautionary Note Regarding Forward-Looking Statements
This news release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this news release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding Generate’s planned participation in investor conferences; the timing, progress and format of those conferences; the availability and timing of webcasts and archived replays; the advancement of its drug candidates; the expected enhancements, benefits, and potential of The Generate Platform; and other future expectations. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “would,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “believe,” “estimate,” “predict,” “potential,” or “continue,” or the negative of these terms or other similar expressions.

These forward-looking statements are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties, and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including, but not limited to, risks and uncertainties related to Generate’s ability to successfully develop and obtain regulatory approval for its drug candidates; the initiation, design, progress, timing, and results of preclinical studies and clinical trials; Generate’s ability to obtain, maintain, and enforce intellectual property protection; Generate’s dependence on third parties for the manufacture and development of its drug candidates; the impact of competitive products and technologies; Generate’s ability to replicate results from earlier preclinical studies or clinical trials in current or future clinical trials; Generate’s ability to demonstrate that its drug candidates are safe and effective for their proposed indications; Generate’s ability to obtain additional capital to fund its operations; and general economic, industry, and market conditions.

Additional information on these and other risks and uncertainties that could affect Generate’s business, financial condition, and results of operations is included in Generate’s filings with the Securities and Exchange Commission, including its Quarterly Reports. The forward-looking statements in this news release are made as of the date hereof, and Generate undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this news release, except as required by applicable law.

Generate Media Contact
Megan McLaughlin
pr@generatebiomedicines.com

NEW YORK, Oct. 22, 2026 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Sunday Lake Gold Corp. (TSX: SNDY; OTCQX: WLBMD), a mineral exploration company, has qualified to trade on the OTCQX® Best Market. Sunday Lake Gold Corp. upgraded to OTCQX from the OTCQB® Venture Market.

Sunday Lake Gold Corp. begins trading today on OTCQX under the symbol “WLBMF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Graduating to the OTCQX Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among U.S. investors.

“We are pleased to be graduating to the OTCQX Best Market,” commented Brian Penny, CEO of Sunday Lake Gold Corp. “Trading on the OTCQX Best Market enhances our visibility and accessibility to the U.S. investment community and provides us with an opportunity to broaden our investor base, improve trading visibility and strengthen our presence in the U.S. capital markets.”

Trading in non-U.S. North American securities on OTC Markets reached $29.38 billion in the third quarter of 2026, representing an 84.22% increase over Q3 2025. OTC Markets recorded $656.81 billion in total dollar volume in the first three quarters of the year. Canada ranked among the top home markets by trading volume during the quarter, highlighting sustained U.S. investor demand for internationally listed names.

About Sunday Lake Gold Corp.
Sunday Lake Gold Corp. is focused on creating value through the exploration and sustainable development of gold projects in Quebec’s Abitibi region while respecting the environment and communities where it operates. The Company holds a contiguous mineral property position totaling 598 km2 that extends approximately 82 km along the Detour-Fenelon gold trend. The property is host to the Company’s flagship PEA-stage Fenelon Gold Project, and its earlier exploration stage Martiniere Gold Project, as well as numerous greenfield gold projects.

About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our public markets: OTCQX® Best Market, OTCQB® Venture Market, OTCID™ Basic Market and Pink Limited™ Market. Our OTC Link® Alternative Trading Systems (ATSs) provide critical market infrastructure that broker-dealers rely on to facilitate trading. Our innovative model offers companies more efficient access to the U.S. financial markets.

OTC Link ATS, OTC Link ECN, OTC Link NQB, OTC Overnight® and MOON ATS® are each an SEC regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC.

To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.

Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428, media@otcmarkets.com

MALVERN, Pa., Oct. 22, 2026 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, will host a conference call and live webcast on Wednesday, November 4, 2026, at 8:30 a.m. ET to provide a business update and report third quarter 2026 financial results. All related materials will be made available on the Ocugen investor website prior to the start of the call.

Conference Call Details
Date:
Wednesday, November 4, 2026
Time:
8:30 a.m. ET
Webcast:
https://edge.media-server.com/mmc/p/w8rytgud 
Participant Event Dial-ins:
+1(800)715-9871 for US callers and +1(646)307-1963 for international callers
Participant Access Code:
6835403

A replay of the call and archived webcast will be available on the Ocugen investor website.

About Ocugen, Inc.
Ocugen, Inc. is a pioneering biotechnology company developing gene therapies for blindness diseases. The Company’s breakthrough modifier gene therapy platform has the potential to address significant unmet medical needs across large patient populations through a gene-agnostic approach. Unlike traditional gene therapies and gene-editing technologies that target a single gene mutation, Ocugen’s modifier gene therapies are designed to address the underlying disease biology by restoring balance across multiple gene networks. The Company is currently advancing programs for inherited retinal diseases and other causes of blindness that affect millions worldwide, including retinitis pigmentosa, Stargardt disease, and geographic atrophy, an advanced form of dry age-related macular degeneration. Discover more at www.ocugen.com and follow Ocugen on LinkedIn and X.

Cautionary Note on Forward-Looking Statements
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties. We may, in some cases, use terms such as “predicts,” “believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks, and uncertainties that may cause actual events or results to differ materially from our current expectations. These and other risks and uncertainties are more fully described in our filings with the Securities and Exchange Commission (SEC), including the risk factors described in the section entitled “Risk Factors” in the quarterly and annual reports that we file with the SEC. Any forward-looking statements that we make in this press release speak only as of the date of this press release. Except as required by law, we assume no obligation to update forward-looking statements contained in this press release whether as a result of new information, future events, or otherwise, after the date of this press release.

Contacts

Investors:
Candice Masse
astr partners
candice.masse@astrpartners.com

Media:
Chris Clark
VP Communications, Ocugen
chris.clark@ocugen.com

NEW YORK, Oct. 22, 2026 (GLOBE NEWSWIRE) — Chicago Atlantic BDC, Inc. (the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company, today announced details for the release of its financial results for the third quarter of 2026.

The Company plans to release its financial results for the third quarter ended September 30, 2026 before the market opens on Thursday, November 12, 2026, and host a conference call and live audio webcast, both open for the general public to hear, later that day at 9:00 a.m. Eastern Time. The number to call for the conference call is 833-630-1956 (international callers: 412-317-1837). The live audio webcast will be available on the Company’s website at investors.chicagoatlanticbdc.com.

A replay of the call will be available at investors.chicagoatlanticbdc.com by the end of day on November 12, 2026.

Call Details – Chicago Atlantic BDC, Inc. Third Quarter 2026 Financial Results:

About Chicago Atlantic BDC, Inc.

The Company is a specialty finance company that has elected to be regulated as a business development company under the 1940 Act, as amended, and has elected to be treated as a regulated investment company for U.S. federal income tax purposes. The Company’s investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a primary focus on cannabis companies. The Company is managed by Chicago Atlantic BDC Advisers, LLC (the “Adviser”), an investment manager focused on the cannabis industry and other niche or underfollowed sectors. For more information, please visit chicagoatlanticbdc.com.

Contact:
Lisa Kampf
Tripp Sullivan
SCR Partners, LLC
LIEN@chicagoatlantic.com

SAN DIEGO, Oct. 22, 2026 (GLOBE NEWSWIRE) — BlossomHill Therapeutics, Inc. (Nasdaq: BLSM), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative small molecule medicines for the treatment of cancer, today announced a collaboration with Foundation Medicine, Inc. to develop a companion diagnostic assay (CDx) for the EGFR C797S resistance mutation. The collaboration will leverage the ongoing Phase 1/2 SOLARA clinical trial evaluating BH-30643 in the targeted treatment of epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) patients to validate the assay.  

EGFR C797S is the most common EGFR mutation driving resistance to osimertinib treatment in EGFR-mutant NSCLC. BH-30643 is a macrocyclic mutant-selective OMNI-EGFR™ inhibitor that has demonstrated clinical activity against a variety of EGFR mutations, in particular the C797S mutation that drives resistance to standard therapy. Understanding and targeting resistance mechanisms to existing EGFR inhibitors is an active area of clinical investigation and drug development. To this end, the collaboration will focus on validating a reliable diagnostic assay for the detection of EGFR C797S mutation to help guide BH-30643’s ongoing development.

“Our near-term development priority for BH-30643 is to address the unmet needs of EGFR-mutant NSCLC patients with known resistance mutations following progression on prior EGFR targeted therapy,” said Geoff Oxnard, MD, Chief Medical Officer at BlossomHill. “Foundation Medicine is the most experienced developer of precision CDx assays and the ideal partner to help us characterize EGFR resistance and validate a CDx assay to support the development of our medicine.”

About BH-30643
BH-30643 is an investigational, novel, orally bioavailable, non-covalent, macrocyclic, brain active, mutant-selective, OMNI-EGFR™ inhibitor for the treatment of EGFR-mutant NSCLC. BH-30643 was designed to overcome the limitations of currently approved EGFR inhibitors, which were discovered over a decade ago without the current, modern understanding of the structure and protein dynamics of mutant EGFRs. In preclinical studies, BH-30643 demonstrated potent inhibitory activity across diverse EGFR mutation categories — classical mutations, on-target resistance mutations such as C797S with or without T790M, atypical mutations and exon 20 insertions — while maintaining marked selectivity over wild-type EGFR. BH-30643 has received Fast Track designation and is being evaluated in SOLARA, a global Phase 1/2, first-in-human clinical trial spanning more than 40 sites in 10 countries. Ongoing dose expansion cohorts are enrolling in both TKI-pretreated and TKI-naive settings, including a C797S resistance cohort. For additional information on SOLARA, including a list of study sites and how to enroll, please visit clinicaltrials.gov (NCT06706076).

About the SOLARA Trial
The Phase 1/2 SOLARA clinical trial (NCT06706076) is a global, open label, multicenter study assessing the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary anti-tumor activity of BH-30643 in patients with epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC). Phase 1 will determine the recommended Phase 2 dose (RP2D) of BH-30643 as a monotherapy and in combination with chemotherapy. Phase 2 is designed to evaluate the antitumor efficacy and safety in specified cohorts determined by mutation subtypes and/or treatment history at the RP2D, as well as the population pharmacokinetics.

About BlossomHill Therapeutics
BlossomHill Therapeutics, Inc. is a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative small molecule medicines that address significant unmet medical needs in cancer treatment. Founded and led by industry veteran J. Jean Cui, Ph.D., with her proven track record in oncology drug design and development – including three FDA-approved drugs – BlossomHill Therapeutics applies cutting-edge science with a goal to address key oncogenic drivers and improve patient outcomes in difficult-to-treat cancers. The company’s lead clinical program is BH-30643, an investigational, non-covalent, macrocyclic, brain active, mutant-selective OMNI-EGFR™ inhibitor for the treatment of EGFR-mutant non-small cell lung cancer (NSCLC), which has received Fast Track designation for the C797S resistance population after 3rd generation EGFR TKI treatment. The company is also conducting clinical development of BH-30236, an investigational macrocyclic CDC-like kinase (CLK) inhibitor initially being studied in a clinical trial for the treatment of relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndromes (HR-MDS). The company’s pipeline also includes BH-501284, a preclinical, non-covalent, selective, pan-KRAS Switch-II inhibitor for potential future development in diverse KRAS-mutant tumors.

BlossomHill Therapeutics is headquartered in San Diego, California. For more information, visit bhtherapeutics.com and follow us on LinkedIn and X.

Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and other federal securities laws, including, without limitation, statements regarding: the therapeutic potential, clinical benefits, safety and potential competitive differentiation of the company’s product candidates, including BH-30643, BH-30236 and BH-501284; the anticipated benefits of regulatory designations received, or that may be received, by the company’s product candidates; the design, enrollment, timing, progress and results of the company’s clinical trials and preclinical studies; the company’s planned regulatory interactions and submissions; anticipated program milestones, including the timing of program and data updates; statements by the company’s management; and the company’s development plans and continued advancement of its pipeline, including the anticipated benefits of the company’s collaboration with Foundation Medicine, Inc. to develop a companion diagnostic assay.

The words “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “upcoming,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.

Any forward-looking statements in this press release are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially, including, without limitation: the company’s limited operating history, history of significant losses and the early stage of development of its product candidates; the risk that preclinical data may not be predictive of results in clinical trials; the risk that preliminary and interim clinical data are subject to further analysis and may not be predictive of, may be inconsistent with, or may be more favorable than, data generated as clinical trials continue or data from future clinical trials; uncertainties inherent in the initiation, timing, design and enrollment of clinical trials, and the availability and timing of data from ongoing and future trials; the company’s ability to successfully demonstrate the safety and efficacy of its product candidates, including for any companion diagnostic, and to obtain and maintain regulatory approvals; the timing and outcome of planned interactions with, and submissions to, the FDA and other regulatory authorities, including whether an accelerated approval pathway will be available to the company; the risk that regulatory designations, including Fast Track and orphan drug designation, may not result in a faster development, review or approval process, may not increase the likelihood of regulatory approval, and may be withdrawn; competition from third parties that are developing products for similar indications; the prior success of the company’s management team not being indicative of future success; the company’s reliance on third parties, including contract research organizations, contract manufacturing organizations and collaborators; the company’s ability to obtain, maintain and protect its intellectual property; and the company’s need for additional financing and its estimates regarding operating expenses and capital requirements.

These and other risks are described in greater detail under the heading “Risk Factors” in the company’s filings with the Securities and Exchange Commission (the “SEC”), including the company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, as well as in the company’s subsequent filings with the SEC. Any forward-looking statements represent the company’s views only as of the date of this press release, and the company expressly disclaims any obligation to update any forward-looking statements, except as required by law.

Company Contacts:
Investors:
Michael Moore, BlossomHill Therapeutics
michael.moore@bhtherapeutics.com

Media:
Ashlea Kosikowski, 1AB
ashlea@1abmedia.com

SAN FRANCISCO, Oct. 22, 2026 (GLOBE NEWSWIRE) — Serve Robotics Inc. (“Serve”) (Nasdaq: SERV), a leading autonomous robotics company, today announced that it will report its 2026 third quarter financial results Thursday, November 5, 2026 after market close.

Conference Call and Webcast Information
Company management will host a conference call at 2 p.m. PT/5 p.m. ET on November 5, 2026 to review the 2026 third quarter financial results. A live audio webcast will be available at investors.serverobotics.com and a replay will be available at the same location.

About Serve Robotics
Serve Robotics (Nasdaq: SERV) designs and operates autonomous robots that navigate complex, human-centric environments. Since spinning off from Uber in 2021, Serve has deployed more than 2,000 robots across the U.S., reaching a population of approximately 3 million and supporting delivery for more than 4,000 restaurants. In 2026, Serve acquired Diligent Robotics, expanding its operations beyond sidewalk delivery into indoor service robots used in hospitals. Serve designs both the hardware and software behind its robots, enabling them to work safely in public and private environments at scale.

For more information, visit www.serverobotics.com or follow the company on X, Instagram, and LinkedIn @serverobotics.

Contacts
Media
press@serverobotics.com

Investor Relations
investor.relations@serverobotics.com

OPERATING PERFORMANCE ACCELERATES
PPNR RATIO SURPASSES 2% AND OPERATING RETURN ON TANGIBLE COMMON EQUITY TOPS 15%
KEY METRICS STRENGTHENED BY BALANCE SHEET RESTRUCTURING 
TOTAL LOANS AND AVERAGE CLIENT DEPOSITS BOTH ACHIEVE 11% SEQUENTIAL ANNUALIZED GROWTH
NET INTEREST MARGIN EXPANDS TO 3.44%
COMMON AND PREFERRED DIVIDENDS DECLARED

ENGLEWOOD CLIFFS, N.J., Oct. 22, 2026 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today reported net income available to common stockholders of $29.9 million for the third quarter of 2026 compared with $40.2 million for the second quarter of 2026 and $39.5 million for the third quarter of 2025.  Diluted earnings per share was $0.59 for the third quarter of 2026 compared with $0.80 for the second quarter of 2026 and $0.78 for the third quarter of 2025.  Return on average assets was 0.86%, 1.17% and 1.16% for the three months ended September 30, 2026, June 30, 2026 and September 30, 2025, respectively.  Return on average tangible common equity was 10.1%, 13.8% and 14.7% for the three months ended September 30, 2026, June 30, 2026 and September 30, 2025, respectively. Third quarter results include a $23.0 million pretax charge related to the balance sheet restructuring and repositioning, discussed below.

Operating net income available to common stockholders (which excludes the $23.0 million pretax restructuring charge, among other non-operating items – see supplemental tables discussed below) was $47.9 million for the third quarter of 2026, $42.2 million for the second quarter of 2026 and $35.5 million for the third quarter of 2025.  Operating diluted earnings per share was $0.95 for the third quarter of 2026, $0.84 for the second quarter of 2026 and $0.70 for the third quarter of 2025.  Operating return on average assets was 1.35%, 1.23% and 1.05% for the three months ended September 30, 2026, June 30, 2026 and September 30, 2025, respectively.  Operating return on average tangible common equity was 15.2%, 13.8% and 12.6% for the three months ended September 30, 2026, June 30, 2026 and September 30, 2025, respectively. Pre-provision net operating revenue (“Operating PPNR”) as a percentage of average assets was 2.01%, 1.94% and 1.61% for the three months ended September 30, 2026, June 30, 2026 and September 30, 2025, respectively. See supplemental tables for a complete reconciliation of GAAP earnings to operating earnings and other non-GAAP measures.

The decrease in net income available to common stockholders and diluted earnings per share for the third quarter of 2026, compared to the second quarter of 2026, was primarily due to the $23.0 million pretax restructuring charge related to the above-mentioned balance sheet repositioning. This charge was partially offset by a $3.7 million increase in net interest income, a $3.3 million reduction in the provision for credit losses and a $5.2 million decrease in income tax expense.  Compared to the third quarter of 2025, the decrease in net income available to common stockholders and diluted earnings per share was primarily due to a $33.9 million decrease in noninterest income. The decrease in noninterest income was mainly attributable to the aforementioned $23.0 million pretax charge in the third quarter of 2026, as well as $10.1 million of non-recurring income recognized in the third quarter of 2025, consisting of a $6.6 million employee retention tax credit (“ERTC”) and a $3.5 million defined benefit pension plan curtailment gain. The decrease was partially offset by a $15.3 million increase in net interest income, a $5.3 million decrease in income tax expense, a $3.3 million decrease in noninterest expenses and a $0.5 million reduction in the provision for credit losses.

Balance Sheet Restructuring and Repositioning

The transaction.  During the third quarter of 2026, the Company completed a strategic review of its balance sheet. As a result, during the fourth quarter, the Company entered into an agreement to sell a pool of up to approximately $750 million in unpaid principal balance of non-relationship multifamily loans, subject to adjustment as provided for under the transaction agreements, to a single third-party purchaser. Loans secured by NYC rent-stabilized properties represent approximately 61% of the pool. The pool consists of loans originated by ConnectOne Bank (30%) and the First National Bank of Long Island (“FLIC”) (70%), which was acquired by the Company in June 2025. The transaction is expected to close in late October, and the final balance of loans sold will be determined at the closing.

Third quarter impact.  The loan pool was transferred to held-for-sale, at the lower of cost or fair value of $678.9 million as of September 30, 2026, resulting in a $23.0 million pretax loss on loans held-for-sale, recorded in noninterest income. This charge reflects the gross discount on the sale price, substantially offset by the interest-rate and credit purchase accounting marks previously recorded on the FLIC-originated loans, as part of the merger with FLIC’s parent company. The recognized loss on the pool is attributed to increases in market interest rates since the loans were originated. The charge is excluded from operating earnings.

Fourth quarter impact and timing.  The transaction is scheduled to close in late October, 2026. Transaction costs related to the restructuring of approximately $7 to $8 million will be recognized upon closing and payment in the fourth quarter of 2026.

Use of proceeds and benefits.  The majority of net proceeds from the sale are expected to be reinvested in government-guaranteed securities at yields similar to those of the loans sold, with the remaining balance used to pay down wholesale funding. The restructuring reduces the Company’s concentrations in commercial real estate (“CRE”) and NYC rent-stabilized properties while strengthening the Bank’s liquidity position. The Bank’s regulatory CRE concentration ratio declines to approximately 397% proforma for the loan sale from 439% at June 30, 2026, and exposure to NYC rent-stabilized assets is projected to decline to approximately 2% of total loans, from 6% as of June 30, 2026. The balance sheet repositioning also reduced the Bank’s loan-to-deposit ratio to 97.1% at September 30, 2026, and will expand its liquid assets.

“Our core performance was strong and reflects the successful execution of our relationship-driven banking strategy. Operating PPNR exceeded 2% of average assets and operating return on tangible common equity topped 15%,” commented Frank Sorrentino, ConnectOne’s Chairman and Chief Executive Officer. “Loans and average client deposits each grew at an annualized rate of about 11%, and our net interest margin widened to 3.44% despite higher short-term rates and a competitive funding environment. Disciplined expense management kept costs well controlled, and credit quality metrics improved.”

“Furthermore, we executed a definitive agreement to sell a pool of up to approximately $750 million of multifamily loans, executing on the balance sheet repositioning we have been contemplating. By selectively divesting non-relationship loans, this transaction reduces our CRE and rent-stabilized concentrations, strengthens key financial metrics and enhances our financial flexibility, while largely preserving our earnings power.” 

Mr. Sorrentino concluded, “As we approach year-end, we remain focused on operational excellence, disciplined growth and deepening client relationships. With a stronger balance sheet and solid momentum in our core business, we believe ConnectOne is well positioned to create long-term value for our shareholders.”

Dividend Declarations

The Board of Directors declared cash dividends on the Company’s common and outstanding preferred stock.  A cash dividend on common stock of $0.195 per share will be paid on December 1, 2026, to common stockholders of record on November 13, 2026.  A dividend of $0.556620 per depositary share, representing a 1/40th interest in a share of the Company’s 5.25% Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock, Series A, will also be paid on December 1, 2026, to holders of record on November 13, 2026.

Operating Results

Fully taxable equivalent net interest income for the third quarter of 2026 was $118.5 million, an increase of $3.7 million, or 3.2%, from the second quarter of 2026, largely due to a 2 basis-point widening of the net interest margin to 3.44% from 3.42% and a 1.7% increase in average interest-earning assets.  The margin benefited from a 5 basis-point increase in the yield on interest-earning assets, primarily due to loan repricing, partially offset by a 3 basis-point increase in the average cost of deposits, including noninterest-bearing deposits. 

Fully taxable equivalent net interest income for the third quarter of 2026 increased $15.3 million, or 14.8%, from the third quarter of 2025, due to a 33 basis-point widening of the net interest margin to 3.44% from 3.11%, and a 3.9% increase in average interest-earning assets.  The margin benefited from a 15 basis-point increase in the yield on interest-earning assets and a 17 basis-point decrease in the average cost of deposits, including noninterest-bearing deposits.

Noninterest income was $(14.5) million in the third quarter of 2026, $7.9 million in the second quarter of 2026 and $19.4 million in the third quarter of 2025.  Noninterest income for the third quarter of 2026 included the $23.0 million pretax restructuring charge. Excluding this item, noninterest income increased $0.6 million compared to the second quarter of 2026, primarily due to a $1.1 million increase in BOLI income, driven by death benefits recorded in the third quarter of 2026, partially offset by a $0.4 million decrease in net gains on sale of loans held-for-sale, primarily SBA loans.  During the third quarter of 2025, the Company recognized $10.1 million in non-recurring gains, consisting of a $6.6 million one-time benefit related to the ERTC and a $3.5 million defined benefit pension plan curtailment gain. Excluding these items, noninterest income decreased $0.8 million, compared to the third quarter of 2025, primarily due to a $1.9 million decrease in net gains on equity securities and a $0.5 million decrease  in deposit, loan and other income, partially offset by a $1.2 million increase in BOLI income, driven by the aforementioned death benefits and a $0.3 million increase in net gains on sale of loans held-for-sale, primarily SBA loans.

Noninterest expenses were $55.4 million for the third quarter of 2026, $55.4 million for the second quarter of 2026 and $58.7 million for the third quarter of 2025. Noninterest expenses were unchanged compared to the second quarter of 2026, as a $1.4 million increase in salaries and employee benefits was offset by a $0.5 million decrease in occupancy and equipment expenses, a $0.4 million decrease in other expenses, a $0.2 million decrease in marketing and advertising expenses, a $0.2 million decrease in FDIC insurance expense and a $0.1 million decrease in information technology and communication expenses. The $3.3 million decrease compared to the third quarter of 2025 was primarily due to a $2.9 million decrease in merger, restructuring and exit expenses, a $0.9 million decrease in FDIC insurance expense, a $0.4 million decrease in amortization of core deposit intangibles, a $0.1 million decrease in occupancy and equipment expenses and a $0.1 million decrease in other expenses, partially offset by a $0.5 million increase in salaries and employee benefits, a $0.4 million increase in professional and consulting expenses and a $0.2 million increase in marketing and advertising expenses.

Income tax expense was $11.0 million for the third quarter of 2026, $16.2 million for the second quarter of 2026 and $16.3 million for the third quarter of 2025.  The effective tax rates were 26.0%, 28.0% and 28.4% for the third quarter of 2026, second quarter of 2026 and third quarter of 2025, respectively.  The decrease in income tax expense and the effective tax rate for the third quarter of 2026 was primarily due to lower taxable income resulting from the loss on loans held-for-sale related to the balance sheet restructuring.  The projected effective tax rate for the fourth quarter of 2026 is 27.5%.

Asset Quality

The provision for credit losses was $5.0 million for the third quarter of 2026, $8.3 million for the second quarter of 2026 and $5.5 million for the third quarter of 2025.  The provision for credit losses for the third quarter of 2026, reflected core loan growth, charge-offs, and specific reserves, partially offset by the transfer of loans to loans held-for-sale at fair value. The provision in the second quarter of 2026 was elevated primarily due to charge-offs on certain NYC rent-stabilized multifamily loans during the second quarter of 2026.

Nonperforming assets, which include nonaccrual loans and other real estate owned (the Bank had no other real estate owned during the periods reported), were $64.3 million as of September 30, 2026, $79.7 million as of June 30, 2026 and $39.7 million as of September 30, 2025.  Nonperforming assets as a percentage of total assets was 0.44% as of September 30, 2026, compared to 0.55% as of June 30, 2026 and 0.28% as of September 30, 2025.  The ratio of nonaccrual loans to loans receivable was 0.56%, as of September 30, 2026, compared to 0.67% as of June 30, 2026 and 0.35% as of September 30, 2025. The sequential decrease in nonaccrual loans was primarily driven by work-out loan sales, charge-offs and principal payments. Excluding PCD loan charge-offs ($22.2 million in the third quarter of 2026, $4.5 million in the second quarter of 2026 and none in the third quarter of 2025), the annualized net loan charge-off ratio was 0.07% for the third quarter of 2026, 0.71% for the second quarter of 2026 and 0.18% for the third quarter of 2025. The elevated charge-off ratio, excluding PCD charge-offs, for the second quarter of 2026 included charge-offs related to a previously disclosed group of NYC rent-stabilized loans.

The allowance for credit losses (“ACL”) represented 1.06%, 1.18% and 1.38% of loans receivable as of September 30, 2026, June 30, 2026 and September 30, 2025, respectively.  The ACL decreased $19.5 million to $120.6 million as of September 30, 2026, compared to $140.1 million as of June 30, 2026, primarily reflecting the charge-off of $22.2 million of allowance on PCD loans in connection with the pending loan sale, partially offset by provision expense in excess of non-PCD net charge-offs. The charge-offs associated with the pending loan sale related to PCD loans for which an allowance for credit losses had previously been established in connection with the FLIC acquisition and required no additional provision for credit losses in the current quarter. The ACL as a percentage of nonaccrual loans was 187.5% as of September 30, 2026, 175.9% as of June 30, 2026 and 394.5% as of September 30, 2025.  Criticized and classified loans as a percentage of loans receivable were 2.02% as of September 30, 2026, compared to 1.89% as of June 30, 2026 and 2.57% as of September 30, 2025.  The increase from June 30, 2026 was primarily due to the decrease in loans receivable resulting from the transfer of loans to held-for-sale; criticized and classified loan balances remained relatively stable during the quarter. Loans past due 30-89 days were 0.05% of loans receivable as of September 30, 2026, 0.03% as of June 30, 2026 and 0.08% as of September 30, 2025.

Selected Balance Sheet Items

The Company’s total assets were $14.8 billion as of September 30, 2026, compared to $14.0 billion as of December 31, 2025.  Loans receivable were $11.4 billion as of September 30, 2026 and $11.5 billion as of December 31, 2025.  Loans receivable as of September 30, 2026 excluded $0.8 billion of loans transferred to held-for-sale. Total deposits were $11.8 billion as of September 30, 2026 and $11.2 billion as of December 31, 2025. 

The Company’s total stockholders’ equity increased to $1.599 billion as of September 30, 2026 from $1.573 billion as of December 31, 2025.  Retained earnings increased $77.7 million, partially offset by an increase in the accumulated other comprehensive loss of $51.0 million.  As of September 30, 2026, the Company’s tangible common equity ratio and tangible book value per share were 8.38% and $24.19, respectively, compared to 8.62% and $23.52, respectively, as of December 31, 2025.  Total goodwill and other intangible assets were $271.6 million as of September 30, 2026 and $280.2 million as of December 31, 2025. Proforma for the loan sale, the tangible common equity ratio was 8.83% as of September 30, 2026.

Share Repurchase Program

During the third quarter of 2026, the Company repurchased 50,000 shares of common stock at an average price of $32.37 per share.  For the nine months ended September 30, 2026, the Company repurchased 140,000 shares of common stock at an average price of $28.26 per share, leaving 501,118 shares authorized for repurchase under the current Board approved repurchase program.  The Company intends to repurchase shares from time to time in the open market, in privately negotiated stock purchases or pursuant to any trading plan that may be adopted in accordance with Rule 10b5-1 of the Securities and Exchange Commission and applicable federal securities laws.  The share repurchase program does not obligate the Company to acquire any particular amount of common stock and the plan may be modified or suspended at any time at the Company’s discretion.

Use of Non-GAAP Financial Measures

In addition to the results presented in accordance with Generally Accepted Accounting Principles (“GAAP”), ConnectOne routinely supplements its evaluation with an analysis of certain non-GAAP measures.  ConnectOne believes these non-GAAP financial measures, in addition to the related GAAP measures, provide meaningful information to investors in understanding our operating performance and trends.  These non-GAAP measures have inherent limitations and are not required to be uniformly applied and are not audited.  They should not be considered in isolation or as a substitute for an analysis of results reported under GAAP.  These non-GAAP measures may not be comparable to similarly titled measures reported by other companies.  Reconciliations of non-GAAP financial measures disclosed in this earnings release to the comparable GAAP measures are provided in the accompanying tables.

Third Quarter 2026 Results Conference Call

Management will host a conference call and audio webcast at 10:00 a.m. ET on Thursday, October 22, 2026, to review the Company’s financial performance and operating results. Chairman and Chief Executive Officer Frank Sorrentino III and Senior Executive Vice President and Chief Financial Officer William S. Burns will host the call.

The conference call dial-in number is 1 (585) 542-9983, meeting ID: 828 757 770. Please dial in at least five minutes before the start of the call to register. An audio webcast of the conference call will be available to the public, on a listen-only basis, via the “Investor Relations” link on the Company’s website at https://www.ConnectOneBank.com or at http://ir.connectonebank.com. An archive of the webcast will be available following the completion of the call at the same locations.

About ConnectOne Bancorp, Inc.

ConnectOne Bancorp, Inc., is a modern financial services company that operates, through its subsidiary, ConnectOne Bank, and the Bank’s fintech subsidiary, BoeFly, Inc. ConnectOne Bank is a high-performing commercial bank offering a full suite of banking & lending products and services that focus on small to middle-market businesses.  BoeFly, Inc. is a fintech marketplace that connects borrowers in the franchise space with funding solutions through a network of partner banks.  ConnectOne Bancorp, Inc. is traded on the Nasdaq Global Market under the trading symbol “CNOB,” and information about ConnectOne may be found at https://www.connectonebank.com.

This news release contains certain forward-looking statements which are based on certain assumptions and describe future plans, strategies, and expectations of the Company.  These forward-looking statements are generally identified by use of the words “believe,” “expect,” “intend,” “anticipate,” “estimate,” “project,” or similar expressions.  The Company’s ability to predict results or the actual effect of future plans or strategies is inherently uncertain.  Factors which could have a material adverse effect on the operations of the Company and its subsidiaries include, but are not limited to, those factors set forth in Item 1A – Risk Factors of the Company’s Annual Report on Form 10-K, as filed with the U.S. Securities and Exchange Commission, as supplemented by the Company’s subsequent filings with the U.S. Securities and Exchange Commission, and changes in interest rates, general economic conditions, legislative/regulatory changes, monetary and fiscal policies of the U.S. Government, including policies of the U.S. Treasury and the Federal Reserve Board, the quality or composition of the loan or investment portfolios, demand for loan products, deposit flows, competition, demand for financial services in the Company’s market area, changes in accounting principles and guidelines and the impact of health emergencies and natural disasters on the Company, its employees and operations, and its customers.  These risks and uncertainties should be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements.  The Company does not undertake, and specifically disclaims any obligation, to publicly release the result of any revisions which may be made to any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

Investor Contact:
William S. Burns
Senior Executive Vice President & CFO
201.816.4474; bill.burns@cnob.com

Media Contact:
Shannan Weeks 
MikeWorldWide
732.299.7890; sweeks@mww.com

 
CONNECTONE BANCORP, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF FINANCIAL CONDITION
(in thousands)

                 
  September 30,     December 31,     September 30,  
  2026     2025     2025  
  (unaudited)             (unaudited)  
ASSETS                      
Cash and due from banks $ 50,643     $ 92,406     $ 96,990  
Interest-bearing deposits with banks   262,705       288,489       445,744  
Cash and cash equivalents   313,348       380,895       542,734  
                       
Investment securities   1,323,789       1,250,938       1,252,202  
Equity securities   21,947       19,287       20,133  
                       
Loans held-for-sale   678,880       391       —  
                       
Loans receivable   11,432,533       11,453,280       11,303,636  
Less: Allowance for credit losses – loans   120,620       154,305       156,499  
Net loans receivable   11,311,913       11,298,975       11,147,137  
                       
Investment in restricted stock, at cost   62,661       54,722       51,516  
Bank premises and equipment, net   48,351       55,285       55,888  
Accrued interest receivable   66,657       60,761       60,630  
Bank owned life insurance   378,361       370,713       367,767  
Right of use operating lease assets   30,228       29,603       29,283  
Goodwill   220,235       220,235       215,611  
Core deposit intangibles   51,387       59,923       63,119  
Other assets   270,948       200,972       217,565  
Total assets $ 14,778,705     $ 14,002,700     $ 14,023,585  
                       
LIABILITIES                      
Deposits:                      
Noninterest-bearing $ 2,479,625     $ 2,420,397     $ 2,513,102  
Interest-bearing   9,298,717       8,820,218       8,856,193  
Total deposits   11,778,342       11,240,615       11,369,295  
Borrowings   1,072,398       903,489       833,443  
Subordinated debentures, net   202,423       201,864       201,677  
Operating lease liabilities   32,807       32,446       33,185  
Other liabilities   94,135       50,946       47,641  
Total liabilities   13,180,105       12,429,360       12,485,241  
                       
COMMITMENTS AND CONTINGENCIES                      
                       
STOCKHOLDERS’ EQUITY                      
Preferred stock   110,927       110,927       110,927  
Common stock   857,765       857,765       857,765  
Additional paid-in capital   41,329       38,763       37,934  
Retained earnings   751,575       673,897       644,944  
Treasury stock   (80,138 )     (76,116 )     (76,116 )
Accumulated other comprehensive loss   (82,858 )     (31,896 )     (37,110 )
Total stockholders’ equity   1,598,600       1,573,340       1,538,344  
Total liabilities and stockholders’ equity $ 14,778,705     $ 14,002,700     $ 14,023,585  
                       

CONNECTONE BANCORP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(dollars in thousands, except for per share data)
 
           
  Three Months Ended     Nine Months Ended  
  09/30/26     09/30/25     09/30/26     09/30/25  
Interest income                              
Interest and fees on loans $ 182,428     $ 165,937     $ 526,976     $ 413,604  
Interest and dividends on investment securities:                              
Taxable   12,580       12,033       34,361       24,457  
Tax-exempt   1,858       2,014       5,743       4,530  
Dividends   843       1,081       2,725       2,758  
Interest on federal funds sold and other short-term investments   2,432       6,644       7,640       13,179  
Total interest income   200,141       187,709       577,445       458,528  
Interest expense                              
Deposits   72,102       75,209       207,355       189,440  
Borrowings   10,741       10,483       30,349       22,432  
Total interest expense   82,843       85,692       237,704       211,872  
                               
Net interest income   117,298       102,017       339,741       246,656  
Provision for credit losses   5,000       5,500       18,500       44,700  
Net interest income after provision for credit losses   112,298       96,517       321,241       201,956  
                               
Noninterest income                              
Deposit, loan and other income   3,347       3,836       9,954       8,412  
Defined benefit pension plan curtailment gain   —       3,501       —       3,501  
Employee retention tax credit   —       6,608       —       6,608  
Income on bank owned life insurance   4,136       2,931       10,104       6,602  
Gains on sale of loans held-for-sale   1,203       859       3,220       1,372  
(Loss) on sale of loans held-for-sale-CRE restructuring   (23,025 )     —       (23,025 )     —  
(Losses) gains on equity securities   (159 )     1,674       (28 )     2,550  
Total noninterest income   (14,498 )     19,409       225       29,045  
                               
Noninterest expenses                              
Salaries and employee benefits   32,922       32,401       97,227       80,212  
Occupancy and equipment   4,968       5,122       15,832       11,280  
FDIC insurance   1,500       2,400       5,200       6,200  
Professional and consulting   3,278       2,929       9,513       7,893  
Marketing and advertising   951       771       3,038       2,206  
Information technology and communications   5,277       5,243       15,914       14,639  
Restructuring and exit charges   —       994       —       994  
Merger expenses and restructuring charges   —       1,898       2,233       33,963  
Bank owned life insurance restructuring charge   —       —       —       327  
Amortization of core deposit intangibles   2,846       3,196       8,536       4,726  
Other expenses   3,627       3,719       11,161       9,187  
Total noninterest expenses   55,369       58,673       168,654       171,627  
                               
Income before income tax expense   42,431       57,253       152,812       59,374  
Income tax expense   11,032       16,277       41,923       18,449  
Net income   31,399       40,976       110,889       40,925  
Preferred dividends   1,509       1,509       4,527       4,527  
Net income available to common stockholders $ 29,890     $ 39,467     $ 106,362     $ 36,398  
                               
Earnings per common share:                              
Basic $ 0.59     $ 0.79     $ 2.12     $ 0.83  
Diluted   0.59       0.78       2.10       0.83  
                               

ConnectOne’s management believes that the supplemental financial information, including non-GAAP measures provided below, is useful to investors. The non-GAAP measures should not be viewed as a substitute for financial results determined in accordance with GAAP, and are not necessarily comparable to non-GAAP financial measures presented by other companies. 

CONNECTONE BANCORP, INC.
SUPPLEMENTAL GAAP AND NON-GAAP FINANCIAL MEASURES
 
     
  As of  
  Sept. 30,     Jun. 30,     Mar. 31,     Dec. 31,     Sept. 30,  
  2026     2026     2026     2025     2025  
Selected Financial Data (dollars in thousands)  
Total assets $ 14,778,705     $ 14,411,864     $ 14,209,561     $ 14,002,700     $ 14,023,585  
Loans receivable:                                      
Commercial $ 1,650,434     $ 1,598,678     $ 1,638,836     $ 1,558,436     $ 1,613,421  
Commercial real estate   4,930,142       4,871,086       4,750,508       4,625,143       4,310,159  
Multifamily   3,057,962       3,679,302       3,574,336       3,437,080       3,420,465  
Commercial construction   585,707       528,103       571,073       623,902       728,615  
Residential   1,207,092       1,192,033       1,202,539       1,210,980       1,233,305  
Consumer   4,306       3,313       1,801       2,017       2,166  
Gross loans   11,435,643       11,872,515       11,739,093       11,457,558       11,308,131  
Net deferred loan fees   (3,110 )     (3,481 )     (3,497 )     (4,278 )     (4,495 )
Loans receivable   11,432,533       11,869,034       11,735,596       11,453,280       11,303,636  
Loans held-for-sale   678,880       —       10,222       391       —  
Total loans $ 12,111,413     $ 11,869,034     $ 11,745,818     $ 11,453,671     $ 11,303,636  
                                       
Investment and equity securities $ 1,345,736     $ 1,199,051     $ 1,215,806     $ 1,270,225     $ 1,272,335  
Goodwill and other intangible assets   271,622       274,468       277,313       280,158       278,730  
Deposits:                                      
Noninterest-bearing demand $ 2,479,625     $ 2,512,964     $ 2,393,938     $ 2,420,397     $ 2,513,102  
Time deposits   3,119,593       2,927,930       3,010,971       2,796,877       2,977,952  
Other interest-bearing deposits   6,179,124       6,299,469       6,108,144       6,023,341       5,878,241  
Total deposits $ 11,778,342     $ 11,740,363     $ 11,513,053     $ 11,240,615     $ 11,369,295  
                                       
Borrowings $ 1,072,398     $ 715,416     $ 827,477     $ 903,489     $ 833,443  
Subordinated debentures (net of debt issuance costs)   202,423       202,236       202,050       201,864       201,677  
Total stockholders’ equity   1,598,600       1,626,525       1,591,547       1,573,340       1,538,344  
                                       
Quarterly Average Balances                                      
Total assets $ 14,534,596     $ 14,254,280     $ 13,999,581     $ 13,963,138     $ 14,050,585  
Loans receivable:                                      
Commercial $ 1,623,410     $ 1,652,412     $ 1,579,368     $ 1,597,123     $ 1,583,673  
Commercial real estate (including multifamily)   8,600,502       8,433,558       8,137,515       7,822,943       7,630,195  
Commercial construction   544,828       524,023       613,661       646,414       704,170  
Residential   1,199,565       1,198,244       1,204,082       1,221,171       1,241,375  
Consumer   10,242       10,855       6,851       5,473       6,747  
Gross loans   11,978,547       11,819,092       11,541,477       11,293,124       11,166,160  
Net deferred loan fees   (3,287 )     (3,331 )     (4,042 )     (4,708 )     (4,418 )
Loans receivable   11,975,260       11,815,761       11,537,435       11,288,416       11,161,742  
Loans held-for-sale   7,623       107       335       230       318  
Total loans $ 11,982,883     $ 11,815,868     $ 11,537,770     $ 11,288,646     $ 11,162,060  
                                       
Investment and equity securities $ 1,307,476     $ 1,208,532     $ 1,256,147     $ 1,269,275     $ 1,274,000  
Goodwill and other intangible assets   273,499       276,313       279,158       279,165       280,814  
Deposits:                                      
Noninterest-bearing demand $ 2,510,843     $ 2,424,773     $ 2,384,883     $ 2,473,596     $ 2,486,993  
Time deposits   2,920,335       2,992,440       2,901,327       2,946,459       3,019,848  
Other interest-bearing deposits   6,252,427       6,122,264       5,996,487       5,907,547       5,889,230  
Total deposits $ 11,683,605     $ 11,539,477     $ 11,282,697     $ 11,327,602     $ 11,396,071  
                                       
Borrowings $ 874,544     $ 812,384     $ 833,551     $ 781,388     $ 783,994  
Subordinated debentures (net of debt issuance costs)   202,300       202,114       201,928       201,741       263,511  
Total stockholders’ equity   1,636,171       1,612,528       1,594,699       1,558,366       1,513,892  
                                       

  Three Months Ended  
  Sept. 30,     Jun. 30,     Mar. 31,     Dec. 31,     Sept. 30,  
  2026     2026     2026     2025     2025  
  (dollars in thousands, except for per share data)  
Net interest income $ 117,298     $ 113,639     $ 108,804     $ 106,595     $ 102,017  
Provision for credit losses   5,000       8,300       5,200       2,300       5,500  
Net interest income after provision for credit losses   112,298       105,339       103,604       104,295       96,517  
Noninterest income                                      
Deposit, loan and other income   3,347       3,324       3,283       3,289       3,836  
Defined benefit pension plan curtailment gain   —       —       —       —       3,501  
Employee retention tax credit   —       —       —       —       6,608  
Income on bank owned life insurance   4,136       3,017       2,951       2,946       2,931  
Gains on sale of loans held-for-sale   1,203       1,590       427       631       859  
(Loss) on sale of loans held-for-sale-CRE restructuring   (23,025 )     —       —       —       —  
(Losses) gains on equity securities   (159 )     (4 )     135       (846 )     1,674  
Total noninterest income   (14,498 )     7,927       6,796       6,020       19,409  
Noninterest expenses                                      
Salaries and employee benefits   32,922       31,537       32,768       31,211       32,401  
Occupancy and equipment   4,968       5,519       5,345       5,265       5,122  
FDIC insurance   1,500       1,700       2,000       2,400       2,400  
Professional and consulting   3,278       3,127       3,108       2,908       2,929  
Marketing and advertising   951       1,161       926       974       771  
Information technology and communications   5,277       5,394       5,243       5,366       5,243  
Restructuring and exit charges   —       —       —       —       994  
Merger expenses and restructuring charges   —       108       2,125       498       1,898  
Branch closing expenses   —       —       —       1,275       —  
Amortization of core deposit intangible   2,846       2,845       2,845       3,196       3,196  
Other expenses   3,627       4,025       3,509       3,853       3,719  
Total noninterest expenses   55,369       55,416       57,869       56,946       58,673  
                                       
Income before income tax expense   42,431       57,850       52,531       53,369       57,253  
Income tax expense   11,032       16,182       14,709       13,851       16,277  
Net income   31,399       41,668       37,822       39,518       40,976  
Preferred dividends   1,509       1,509       1,509       1,509       1,509  
Net income available to common stockholders $ 29,890     $ 40,159     $ 36,313     $ 38,009     $ 39,467  
                                       
Weighted average diluted common shares outstanding   50,455,230       50,404,698       50,382,297       50,414,115       50,462,030  
Diluted EPS $ 0.59     $ 0.80     $ 0.72     $ 0.75     $ 0.78  
                                       
Reconciliation of GAAP Net Income to Operating Net Income:                                      
Net income $ 31,399     $ 41,668     $ 37,822     $ 39,518     $ 40,976  
Restructuring and exit charges   —       —       —       —       994  
Merger expenses and restructuring charges   —       108       2,125       498       1,898  
Branch closing expenses   —       —       —       1,275       —  
Amortization of core deposit intangibles   2,846       2,845       2,845       3,196       3,196  
Loss on sale of loans held-for-sale-CRE restructuring   23,025       —       —       —       —  
Losses (gains) on equity securities   159       4       (135 )     846       (1,674 )
Defined benefit pension plan curtailment gain   —       —       —       —       (3,501 )
Employee retention tax credit   —       —       —       —       (6,608 )
Tax impact of adjustments   (8,069 )     (917 )     (1,499 )     (1,802 )     1,737  
Operating net income $ 49,360     $ 43,708     $ 41,158     $ 43,531     $ 37,018  
Preferred dividends   1,509       1,509       1,509       1,509       1,509  
Operating net income available to common stockholders $ 47,851     $ 42,199     $ 39,649     $ 42,022     $ 35,509  
                                       
Operating diluted EPS (non-GAAP) (1) $ 0.95     $ 0.84     $ 0.79     $ 0.83     $ 0.70  
                                       
Return on Assets Measures                                      
Average assets $ 14,534,596     $ 14,254,280     $ 13,999,581     $ 13,963,138     $ 14,050,585  
Return on avg. assets   0.86 %     1.17 %     1.10 %     1.12 %     1.16 %
Operating return on avg. assets (non-GAAP) (2)   1.35       1.23       1.19       1.24       1.05  
Pre-provision net operating revenue (“PPNR”) return on avg. assets (non-GAAP) (3)   2.01       1.94       1.81       1.75       1.61  

____________________________

(1) Operating net income available to common stockholders divided by weighted average diluted shares outstanding.
(2) Operating net income divided by average assets.
(3) Net income before income tax expense, provision for credit losses, merger expenses and restructuring charges, branch closing expenses, BOLI restructuring charges, restructuring and exit charges, CRE restructuring, employee retention tax credit, defined benefit pension plan curtailment gain, amortization of core deposit intangibles and net gains on equity securities divided by average assets.

  Three Months Ended  
  Sept. 30,     Jun. 30,     Mar. 31,     Dec. 31,     Sept. 30,  
  2026     2026     2026     2025     2025  
Return on Equity Measures (dollars in thousands)  
Average stockholders’ equity $ 1,636,171     $ 1,612,528     $ 1,594,699     $ 1,558,366     $ 1,513,892  
Less: average preferred stock   (110,927 )     (110,927 )     (110,927 )     (110,927 )     (110,927 )
Average common equity $ 1,525,244     $ 1,501,601     $ 1,483,772     $ 1,447,439     $ 1,402,965  
Less: average intangible assets   (273,499 )     (276,313 )     (279,158 )     (279,165 )     (280,814 )
Average tangible common equity $ 1,251,745     $ 1,225,288     $ 1,204,614     $ 1,168,274     $ 1,122,151  
Return on avg. common equity (GAAP)   7.77 %     10.73 %     9.93 %     10.42 %     11.16 %
Operating return on avg. common equity (non-GAAP) (4)   12.45       11.27       10.84       11.52       10.04  
Return on avg. tangible common equity (non-GAAP) (5)   10.10       13.79       12.89       13.66       14.74  
Operating return on avg. tangible common equity (non-GAAP) (6)   15.17       13.81       13.35       14.27       12.55  
                                       
Efficiency Measures                                      
Total noninterest expenses $ 55,369     $ 55,416     $ 57,869     $ 56,946     $ 58,673  
Restructuring and exit charges   —       —       —       —       (994 )
Merger expenses and restructuring charges   —       (108 )     (2,125 )     (498 )     (1,898 )
Branch closing expenses   —       —       —       (1,275 )     —  
Amortization of core deposit intangibles   (2,846 )     (2,845 )     (2,845 )     (3,196 )     (3,196 )
Operating noninterest expense $ 52,523     $ 52,463     $ 52,899     $ 51,977     $ 52,585  
                                       
Net interest income (tax equivalent basis) $ 118,541     $ 114,841     $ 109,976     $ 107,761     $ 103,155  
Noninterest income   (14,498 )     7,927       6,796       6,020       19,409  
Defined benefit pension plan curtailment gain   —       —       —       —       (3,501 )
Employee retention tax credit   —       —       —       —       (6,608 )
Loss on sale of loans held-for-sale-CRE restructuring   23,025       —       —       —       —  
Losses (gains) on equity securities   159       4       (135 )     846       (1,674 )
Operating revenue $ 127,227     $ 122,772     $ 116,637     $ 114,627     $ 110,781  
                                       
Operating efficiency ratio (non-GAAP) (7)   41.3 %     42.7 %     45.4 %     45.3 %     47.5 %
                                       
Net Interest Margin                                      
Average interest-earning assets $ 13,685,961     $ 13,451,804     $ 13,160,794     $ 13,093,053     $ 13,172,443  
Net interest income (tax equivalent basis) $ 118,541     $ 114,841     $ 109,976     $ 107,761     $ 103,155  
Net interest margin (non-GAAP)   3.44 %     3.42 %     3.39 %     3.27 %     3.11 %

____________________________

(4) Operating net income available to common stockholders divided by average common equity.
(5) Net income available to common stockholders, excluding amortization of intangible assets, divided by average tangible common equity.
(6) Operating net income available to common stockholders, divided by average tangible common equity.
(7) Operating noninterest expense divided by operating revenue.

  As of  
  Sept. 30,     Jun. 30,     Mar. 31,     Dec. 31,     Sept. 30,  
  2026     2026     2026     2025     2025  
Capital Ratios and Book Value per Share (dollars in thousands, except for per share data)  
Stockholders equity $ 1,598,600     $ 1,626,525     $ 1,591,547     $ 1,573,340     $ 1,538,344  
Less: preferred stock   (110,927 )     (110,927 )     (110,927 )     (110,927 )     (110,927 )
Common equity $ 1,487,673     $ 1,515,598     $ 1,480,620     $ 1,462,413     $ 1,427,417  
Less: intangible assets   (271,622 )     (274,468 )     (277,313 )     (280,158 )     (278,730 )
Tangible common equity $ 1,216,051     $ 1,241,130     $ 1,203,307     $ 1,182,255     $ 1,148,687  
                                       
Total assets $ 14,778,705     $ 14,411,864     $ 14,209,561     $ 14,002,700     $ 14,023,585  
Less: intangible assets   (271,622 )     (274,468 )     (277,313 )     (280,158 )     (278,730 )
Tangible assets $ 14,507,083     $ 14,137,396     $ 13,932,248     $ 13,722,542     $ 13,744,855  
                                       
Common shares outstanding   50,268,879       50,319,832       50,288,494       50,271,854       50,273,089  
                                       
Common equity ratio (GAAP)   10.07 %     10.52 %     10.42 %     10.44 %     10.18 %
Tangible common equity ratio (non-GAAP) (8)   8.38       8.78       8.64       8.62       8.36  
                                       
Regulatory capital ratios (Bancorp):                                      
Leverage ratio   9.80 %     9.85 %     9.79 %     9.61 %     9.35 %
Common equity Tier 1 risk-based ratio   10.10       10.28       10.23       10.24       10.17  
Risk-based Tier 1 capital ratio   11.01       11.22       11.19       11.22       11.17  
Risk-based total capital ratio   13.44       13.71       13.81       13.88       13.88  
                                       
Regulatory capital ratios (Bank):                                      
Leverage ratio   10.78 %     10.81 %     10.81 %     10.59 %     10.35 %
Common equity Tier 1 risk-based ratio   12.11       12.31       12.35       12.36       12.37  
Risk-based Tier 1 capital ratio   12.11       12.31       12.35       12.36       12.37  
Risk-based total capital ratio   12.99       13.20       13.33       13.33       13.38  
                                       
Book value per share (GAAP) $ 29.59     $ 30.12     $ 29.44     $ 29.09     $ 28.39  
Tangible book value per share (non-GAAP) (9)   24.19       24.66       23.93       23.52       22.85  
                                       
Net Loan Charge-offs (Recoveries) (10):                                      
Charge-offs $ 3,179     $ 17,022     $ 2,758     $ 5,613     $ 5,174  
Recoveries   (941 )     (531 )     (467 )     (836 )     (38 )
Net loan charge-offs $ 2,238     $ 16,491     $ 2,291     $ 4,777     $ 5,136  
Net loan charge-offs as a % of average loans receivable (annualized)   0.07 %     0.56 %     0.08 %     0.17 %     0.18 %
                                       
Asset Quality                                      
Nonaccrual loans $ 64,330     $ 79,664     $ 41,579     $ 45,915     $ 39,671  
Other real estate owned   —       —       —       —       —  
Nonperforming assets $ 64,330     $ 79,664     $ 41,579     $ 45,915     $ 39,671  
                                       
Allowance for credit losses – loans (excluding nonaccretable credit marks) $ 108,818     $ 106,120     $ 115,609     $ 112,282     $ 113,163  
Add: nonaccretable credit marks   11,802       34,029       37,447       42,023       43,336  
Allowance for credit losses – loans (“ACL”) $ 120,620     $ 140,149     $ 153,056     $ 154,305     $ 156,499  
                                       
Loans receivable $ 11,432,533     $ 11,869,034     $ 11,735,596     $ 11,453,280     $ 11,303,636  
                                       
Nonaccrual loans as a % of loans receivable   0.56 %     0.67 %     0.35 %     0.40 %     0.35 %
Nonperforming assets as a % of total assets   0.44       0.55       0.29       0.33       0.28  
ACL as a % of loans receivable   1.06       1.18       1.30       1.35       1.38  
ACL as a % of nonaccrual loans   187.5       175.9       368.1       336.1       394.5  

____________________________

(8) Tangible common equity divided by tangible assets.
(9) Tangible common equity divided by common shares outstanding at period-end.
(10) Includes only non-PCD loans.

CONNECTONE BANCORP, INC.
NET INTEREST MARGIN ANALYSIS
(dollars in thousands)

     
  For the Three Months Ended  
  September 30, 2026     June 30, 2026     September 30, 2025  
Interest-earning assets: Average Balance     Interest     Rate(7)     Average Balance     Interest     Rate(7)     Average Balance     Interest     Rate(7)  
Investment securities (1) (2) $ 1,387,589     $ 14,931       4.27 %   $ 1,275,125     $ 13,397       4.21 %   $ 1,355,775     $ 14,581       4.27 %
Loans receivable and loans held-for-sale (2) (3) (4)   11,982,883       183,178       6.06       11,815,868       176,944       6.01       11,162,060       166,541       5.92  
Federal funds sold and interest-     ​       ​       ​       ​       ​       ​       ​       ​       ​
bearing deposits with banks   262,118       2,432       3.68       309,872       2,821       3.65       605,344       6,644       4.35  
Restricted investment in bank stock   53,371       843       6.27       50,939       947       7.46       49,264       1,081       8.71  
Total interest-earning assets   13,685,961       201,384       5.84       13,451,804       194,109       5.79       13,172,443       188,847       5.69  
Allowance for loan losses   (142,006 )       ​       ​     (155,399 )       ​       ​     (159,157 )       ​       ​
Noninterest-earning assets   990,641         ​       ​     957,875         ​       ​     1,037,299         ​       ​
Total assets $ 14,534,596         ​       ​   $ 14,254,280         ​       ​   $ 14,050,585         ​       ​
      ​       ​       ​       ​       ​       ​       ​       ​       ​
Interest-bearing liabilities:     ​       ​       ​       ​       ​       ​       ​       ​       ​
Money market deposits   3,065,588       22,998       2.98       3,052,487       22,148       2.91       3,041,528       24,578       3.21  
Savings deposits   942,742       6,234       2.62       978,961       6,339       2.60       949,775       7,198       3.01  
Time deposits   2,920,335       27,603       3.75       2,992,440       27,776       3.72       3,019,848       30,072       3.95  
Other interest-bearing deposits   2,244,097       15,267       2.70       2,090,816       13,308       2.55       1,897,927       13,361       2.79  
Total interest-bearing deposits   9,172,762       72,102       3.12       9,114,704       69,571       3.06       8,909,078       75,209       3.35  
      ​       ​       ​       ​       ​       ​       ​       ​       ​
Borrowings   874,544       6,393       2.90       812,384       5,402       2.67       783,994       4,550       2.30  
Subordinated debentures   202,300       4,337       8.51       202,114       4,283       8.50       263,511       5,917       8.91  
Finance lease   769       11       5.68       845       12       5.70       1,068       16       5.94  
Total interest-bearing liabilities   10,250,375       82,843       3.21       10,130,047       79,268       3.14       9,957,651       85,692       3.41  
      ​       ​       ​       ​       ​       ​       ​       ​       ​
Noninterest-bearing demand deposits   2,510,843         ​       ​     2,424,773         ​       ​     2,486,993         ​       ​
Other liabilities   137,207         ​       ​     86,932         ​       ​     92,049         ​       ​
Total noninterest-bearing liabilities   2,648,050         ​       ​     2,511,705         ​       ​     2,579,042         ​       ​
Stockholders’ equity   1,636,171         ​       ​     1,612,528         ​       ​     1,513,892         ​       ​
Total liabilities and stockholders’ equity $ 14,534,596         ​       ​   $ 14,254,280         ​       ​   $ 14,050,585         ​       ​
      ​       ​       ​       ​       ​       ​       ​       ​       ​
Net interest income (tax equivalent basis)     ​     118,541         ​       ​     114,841         ​       ​     103,155         ​
Net interest spread (5)     ​       ​     2.63 %       ​       ​     2.65 %       ​       ​     2.28 %
      ​       ​       ​       ​       ​       ​       ​       ​       ​
Net interest margin (6)     ​       ​     3.44 %       ​       ​     3.42 %       ​       ​     3.11 %
      ​       ​       ​       ​       ​       ​       ​       ​       ​
Tax equivalent adjustment     ​     (1,243 )       ​       ​     (1,202 )       ​       ​     (1,138 )       ​
Net interest income     ​   $ 117,298         ​       ​   $ 113,639         ​       ​   $ 102,017         ​

____________________________

(1) Average balances are calculated on amortized cost.
(2) Interest income is presented on a tax equivalent basis using 21% federal tax rate.
(3) Includes loan fee income.
(4) Loans include nonaccrual loans.
(5) Represents difference between the average yield on interest-earning assets and the average cost of interest-bearing liabilities and is presented on a tax equivalent basis.
(6) Represents net interest income on a tax equivalent basis divided by average total interest-earning assets.
(7) Rates are annualized.

This press release was published by a CLEAR® Verified individual.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.